https://curecurrent.com/trials/clinical-study-of-kdt-3594-in-healthy-adult-males-and-patients-with-parkinson-s-disease-69002https://curecurrent.com/trials/effect-of-short-term-motilitone-therapy-on-health-related-quality-of-life-in-pd-patients-with-gastrointestinal-symptoms-69003https://curecurrent.com/trials/open-label-study-of-nelotanserin-in-lewy-body-dementia-with-visual-hallucinations-or-rem-sleep-behavior-disorder-69004https://curecurrent.com/trials/feasibility-of-the-aha-exergame-system-in-parkinson-s-disease-patients-69005https://curecurrent.com/trials/prism-adaptation-treatment-of-parkinson-s-disease-69006https://curecurrent.com/trials/impact-of-walking-practice-on-persons-with-pd-69007https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-pharmacodynamics-and-safety-of-opicapone-in-subjects-with-parkinson-s-disease-taking-lev-69008https://curecurrent.com/trials/comparing-the-therapeutic-efficacy-and-safety-of-da-9701-with-domperidone-in-patients-with-parkinson-s-disease-69009https://curecurrent.com/trials/effects-of-a-high-intensity-progressive-cycle-program-on-quality-of-life-and-motor-symptomatology-in-parkinson-s-disease-69010https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-treatment-for-parkinson-disease-69011https://curecurrent.com/trials/immersive-virtual-reality-to-improve-gait-in-parkinson-s-disease-69012https://curecurrent.com/trials/the-effects-of-dbs-of-subthalam-c-nucleus-on-functionality-in-pat-ents-with-parkinson-s-disease-short-term-results-69013https://curecurrent.com/trials/electrophysiology-of-brain-activity-during-electrode-implantation-in-patients-treated-with-deep-brain-stimulation-69014https://curecurrent.com/trials/the-effect-of-deep-brain-stimulation-on-facial-expressions-69015https://curecurrent.com/trials/role-of-retina-in-mechanisms-of-illusions-and-visual-hallucinations-observed-in-idiopathic-parkinson-s-disease-69016https://curecurrent.com/trials/effects-of-deep-brain-stimulation-dbs-frequency-on-neural-synchrony-69017https://curecurrent.com/trials/one-year-follow-up-of-iron-in-basal-ganglia-r2-a-biomarker-of-parkinson-s-disease-progression-69018https://curecurrent.com/trials/randomized-trial-to-test-the-coordinated-care-for-health-promotion-and-activities-in-parkinson-s-disease-intervention-in-69019https://curecurrent.com/trials/exercise-and-cognitive-training-in-parkinson-s-disease-69020https://curecurrent.com/trials/acupuncture-for-management-of-balance-impairment-in-patients-with-parkinson-s-disease-69021https://curecurrent.com/trials/rhythmic-entrainment-in-bilingual-speakers-with-dysarthria-69022https://curecurrent.com/trials/telephone-based-counseling-for-depression-in-parkinson-s-disease-69023https://curecurrent.com/trials/a-study-of-tolerability-and-efficacy-of-cannabidiol-on-tremor-in-parkinson-s-disease-69024https://curecurrent.com/trials/study-to-evaluate-the-impact-of-using-wearable-devices-in-addition-to-standard-clinical-practice-on-parkinson-s-subject-69025https://curecurrent.com/trials/the-influence-of-manual-and-verbal-guidance-for-therapeutic-results-in-people-with-parkinson-s-disease-69026https://curecurrent.com/trials/cough-according-to-stimulus-type-in-pd-69027https://curecurrent.com/trials/the-role-of-cerebellar-hyperactivity-in-parkinson-s-disease-69028https://curecurrent.com/trials/turkish-version-of-mini-bestest-validity-and-reliability-for-adult-participants-with-sensoriomotor-impairments-69029https://curecurrent.com/trials/effect-of-l-dihydoxyphenylserine-on-locomotion-postural-stability-and-fall-risk-reduction-in-parkinson-disease-69030https://curecurrent.com/trials/bone-mineral-density-changes-among-clinical-subtypes-of-parkinson-s-disease-69031https://curecurrent.com/trials/evaluation-of-a-speech-to-noise-feedback-device-for-treatment-of-hypophonia-in-parkinson-s-disease-69032https://curecurrent.com/trials/effects-of-motor-imagery-training-on-gait-and-brain-activation-pattern-of-individuals-with-parkinson-s-disease-69033https://curecurrent.com/trials/deep-brain-stimulation-to-treat-symptoms-of-parkinson-s-disease-69034https://curecurrent.com/trials/post-market-brio-system-deep-brain-stimulation-dbs-pd-study-69035https://curecurrent.com/trials/prevalence-of-age-related-macular-degeneration-armd-in-parkinson-s-patients-and-assesment-of-the-role-of-l-dopa-69036https://curecurrent.com/trials/distant-delivery-of-a-mindfulness-based-intervention-for-people-affected-by-parkinson-s-disease-69037https://curecurrent.com/trials/a-study-on-the-treatment-of-parkinson-s-disease-with-autologous-neural-stem-cells-69038https://curecurrent.com/trials/patient-and-caregiver-reported-symptoms-and-outcomes-with-levodopa-carbidopa-intestinal-gel-for-the-treatment-of-advance-69039https://curecurrent.com/trials/safety-tolerability-and-effects-of-mannitol-in-parkinson-s-disease-69040https://curecurrent.com/trials/safety-efficacy-of-tigan-to-control-nausea-vomiting-experienced-during-apokyn-initiation-and-treatment-69041https://curecurrent.com/trials/leap-a-new-overground-body-weight-support-robot-usability-trial-69042https://curecurrent.com/trials/effect-of-donepezil-on-cognition-in-parkinson-s-disease-with-mild-cognitive-impairment-pd-mci-69043https://curecurrent.com/trials/predictive-factors-of-short-long-term-outcome-and-complications-of-bilateral-dbs-in-pd-69044https://curecurrent.com/trials/treadmill-in-the-rehabilitation-of-parkinsonian-gait-69045https://curecurrent.com/trials/cryotherapy-versus-radiofrequency-catheter-ablation-research-program-69046https://curecurrent.com/trials/eonoff-d1-extension-69047https://curecurrent.com/trials/a-feasibility-study-to-evaluate-safety-and-initial-effectiveness-of-exablate-transcranial-mr-guided-focused-ultrasound-f-69048https://curecurrent.com/trials/precision-medical-diagnosis-and-acupuncture-treatment-for-parkinson-s-disease-69049https://curecurrent.com/trials/biomarker-analysis-for-gba-associated-parkinson-s-disease-69050https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-severity-of-motor-dysfunction-in-parkinson-s-disease-based-on-ai-video-analysis-69051https://curecurrent.com/trials/the-effects-of-a-high-intensity-exercise-training-program-in-patients-with-parkinson-s-disease-69052https://curecurrent.com/trials/safety-and-efficacy-study-of-syn115-in-parkinson-s-patients-using-levodopa-to-treat-end-of-dose-wearing-off-69053https://curecurrent.com/trials/phenomenological-and-psychopathological-factors-associated-to-hallucinations-in-parkinson-s-disease-69054https://curecurrent.com/trials/the-fine-motor-dexterity-under-dual-task-in-parkinson-s-disease-69055https://curecurrent.com/trials/effects-of-different-percentages-body-weight-supported-treadmill-training-on-gait-balance-quality-of-life-and-fatigue-in-69056https://curecurrent.com/trials/multi-electrodes-set-for-deep-brain-stimulation-in-parkinson-disease-69057https://curecurrent.com/trials/personality-as-a-predictive-factor-of-therapeutic-response-on-quality-of-life-after-continuous-perfusion-of-dopaminergic-69058https://curecurrent.com/trials/the-prevalence-of-wearing-off-in-patients-with-parkinson-s-disease-in-shanghai-69059https://curecurrent.com/trials/the-effect-of-tdcs-on-subcortical-brain-functioning-69060https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-iti-214-in-parkinson-s-disease-69061https://curecurrent.com/trials/3d-or-2d-upper-extremity-exergaming-for-persons-with-parkinson-s-disease-69062https://curecurrent.com/trials/effectiveness-of-mirt-on-hand-and-finger-dexterity-in-pd-patients-69063https://curecurrent.com/trials/moving-through-glass-an-augmented-reality-device-application-for-persons-with-parkinson-s-disease-69064https://curecurrent.com/trials/physical-training-induced-plasticity-of-motor-control-mechanisms-in-parkinson-s-disease-patients-69065https://curecurrent.com/trials/low-dose-apomorphine-and-parkinsonism-69066https://curecurrent.com/trials/methylphenidate-and-parkinson-s-disease-69067https://curecurrent.com/trials/atomoxetine-for-freezing-of-gait-in-parkinson-s-disease-69068https://curecurrent.com/trials/multimodal-exercise-program-on-parkinson-s-disease-patients-with-depression-69069https://curecurrent.com/trials/a-study-in-patients-with-advanced-parkinson-s-disease-to-assess-the-relative-bioavailability-of-levodopa-administered-as-69070https://curecurrent.com/trials/treatment-of-parkinson-disease-and-multiple-system-atrophy-using-intranasal-insulin-69071https://curecurrent.com/trials/gait-disorders-in-parkinson-s-disease-69072https://curecurrent.com/trials/exercise-and-parkinson-s-comparing-interventions-and-exploring-neural-mechanisms-69073https://curecurrent.com/trials/study-on-the-visual-condition-in-parkinson-s-disease-69074https://curecurrent.com/trials/rehabilitation-of-postural-abnormalities-in-parkinson-s-disease-69075https://curecurrent.com/trials/modified-exercise-programme-in-individuals-with-parkinson-s-disease-69076https://curecurrent.com/trials/prismatic-lenses-in-the-pisa-syndrome-69077https://curecurrent.com/trials/the-effects-of-auditory-cues-on-gait-mechanics-in-parkinson-s-disease-69078https://curecurrent.com/trials/dyskinesia-in-parkinson-s-disease-study-p04501-69079https://curecurrent.com/trials/pharmacokinetic-study-of-ly03003-in-patients-with-parkinson-s-disease-69080https://curecurrent.com/trials/a-dose-finding-study-of-preladenant-sch-420814-for-the-treatment-of-parkinson-s-disease-pd-in-japanese-patients-p06402-69081https://curecurrent.com/trials/acute-effects-of-preladenant-sch-420814-on-dyskinesia-and-parkinsonism-in-levodopa-treated-participants-p05550-69082https://curecurrent.com/trials/a-placebo-and-active-controlled-study-of-preladenant-in-early-parkinson-s-disease-pd-p05664-69083https://curecurrent.com/trials/a-placebo-and-active-controlled-study-of-preladenant-in-subjects-with-moderate-to-severe-parkinson-s-disease-p04938-69084https://curecurrent.com/trials/transcutaneous-submandibular-gland-biopsy-feasibility-of-repeat-biopsy-as-a-progression-marker-for-parkinson-s-disease-69085https://curecurrent.com/trials/an-active-controlled-extension-study-to-nct01155466-p04938-and-nct01227265-p07037-p06153-69086https://curecurrent.com/trials/protocol-balance-training-in-parkinson-s-disease-69087https://curecurrent.com/trials/comparison-of-continuous-and-pulsatile-apomorphine-in-parkinson-s-disease-69088https://curecurrent.com/trials/idebenone-treatment-of-early-parkinson-s-diseasesymptoms-69089https://curecurrent.com/trials/frontal-cortex-and-gait-freezing-in-parkinson-s-disease-rehabilitation-impact-69090https://curecurrent.com/trials/sudoscan-as-a-biomarker-of-parkinson-s-disease-69091https://curecurrent.com/trials/effectiveness-and-reliability-of-hypnosis-in-stereotaxy-69092https://curecurrent.com/trials/exploit-the-neural-source-and-the-feasibility-of-transcranial-direct-current-stimulation-for-freezing-of-gait-in-parkins-69093https://curecurrent.com/trials/facilitating-motor-skill-learning-in-parkinson-s-disease-69094https://curecurrent.com/trials/the-reliability-validity-and-responsiveness-of-the-timed-360-turn-test-in-patients-with-parkinson-s-disease-69095https://curecurrent.com/trials/the-effect-of-transcranial-direct-current-stimulation-tdcs-on-depression-in-pd-69096https://curecurrent.com/trials/autocorrelated-rhythmic-auditory-stimulations-for-parkinson-s-disease-patients-69097https://curecurrent.com/trials/efficacy-study-of-light-therapy-as-an-adjunctive-treatment-for-parkinson-s-disease-69098https://curecurrent.com/trials/long-term-transcranial-direct-current-stimulation-in-parkinson-s-disease-69099https://curecurrent.com/trials/gut-microbiota-and-parkinson-s-disease-69100https://curecurrent.com/trials/bioavailability-and-bioequivalence-study-of-two-different-sources-of-opicapone-69101https://curecurrent.com/trials/efficacy-and-safety-of-opicapone-in-clinical-practice-69102https://curecurrent.com/trials/nigrosomal-iron-imaging-in-parkinson-s-disease-69103https://curecurrent.com/trials/prevention-of-levodopa-induced-dyskinesias-by-transcranial-static-magnetic-field-stimulation-tsms-69104https://curecurrent.com/trials/investigating-the-microstructural-and-functional-alterations-of-brain-in-parkinson-s-disease-patients-69105https://curecurrent.com/trials/varenicline-treatment-for-excessive-daytime-sleepiness-in-parkinson-s-disease-69106https://curecurrent.com/trials/cholinesterase-inhibitors-to-slow-progression-of-visual-hallucinations-in-parkinson-apos-s-disease-69107https://curecurrent.com/trials/evaluation-of-the-diagnostic-efficacy-and-safety-of-123i-nav5001-as-an-imaging-agent-to-aid-in-the-diagnosis-of-parkinso-69108https://curecurrent.com/trials/developing-a-novel-imaging-biomarker-in-the-differential-diagnosis-of-parkinson-s-disease-and-parkinsonism-69109https://curecurrent.com/trials/impact-of-non-traditional-guitar-group-instruction-on-functional-movement-and-well-being-in-parkinson-s-disease-patients-69110https://curecurrent.com/trials/a-study-to-assess-pharmacokinetics-pk-of-preladenant-in-participants-with-chronic-renal-impairment-cri-p06512-69111https://curecurrent.com/trials/a-responsive-closed-loop-approach-to-treat-freezing-of-gait-in-parkinson-s-disease-69112https://curecurrent.com/trials/clinical-evaluation-of-ropinirole-pr-xr-tablets-in-monotherapy-for-parkinson-s-disease-pd-69113https://curecurrent.com/trials/the-cyclical-lower-extremity-exercise-for-parkinson-s-trial-69114https://curecurrent.com/trials/a-study-of-movement-disorders-using-the-qmat-at-home-testing-device-69115https://curecurrent.com/trials/safety-and-clinical-outcomes-study-svf-deployment-for-orthopedic-neurologic-urologic-and-cardio-pulmonary-conditions-69116https://curecurrent.com/trials/a-study-to-assess-pharmacokinetics-of-preladenant-in-participants-with-chronic-hepatic-impairment-p06513-69117https://curecurrent.com/trials/emst-and-tms-for-treatment-of-dysphagia-in-parkinson-s-disease-69118https://curecurrent.com/trials/placebo-controlled-study-of-preladenant-in-participants-with-moderate-to-severe-parkinson-s-disease-p07037-69119https://curecurrent.com/trials/mental-practice-combined-with-physical-practice-to-improve-the-gait-performance-of-people-with-parkinson-s-disease-69120https://curecurrent.com/trials/neurophysiological-dissection-and-intervention-of-freezing-of-gait-in-parkinson-s-disease-69121https://curecurrent.com/trials/azilect-rasagiline-in-levodopa-treated-parkinson-s-patients-with-motor-fluctuations-in-china-69122https://curecurrent.com/trials/training-and-parkinson-s-69123https://curecurrent.com/trials/assessment-of-perampanel-e2007-on-synaptic-dopamine-in-mild-moderate-pd-patients-a-pilot-study-with-123i-ibzm-spect-69124https://curecurrent.com/trials/glp1r-in-parkinson-s-disease-69125https://curecurrent.com/trials/a-study-to-understand-safety-and-plasma-concentrations-of-pf-06669571-during-and-following-the-oral-administration-of-si-69126https://curecurrent.com/trials/serotonin-and-amyloidopathy-69127https://curecurrent.com/trials/outcomes-data-of-adipose-stem-cells-to-treat-parkinson-s-disease-69128https://curecurrent.com/trials/dynamic-aspects-of-internal-pre-activation-of-effects-sensors-of-voluntary-action-in-parkinson-s-disease-69129https://curecurrent.com/trials/trial-to-evaluate-the-efficacy-of-rotigotine-on-parkinson-s-disease-associated-motor-symptoms-and-apathy-69130https://curecurrent.com/trials/gdnf-in-ideopathicparkinsons-disease-69131https://curecurrent.com/trials/mutations-associated-with-parkinson-s-disease-69132https://curecurrent.com/trials/n-acetylcysteine-for-neuroprotection-in-parkinson-s-disease-69133https://curecurrent.com/trials/high-intensity-group-vocal-exercise-to-improve-laryngeal-function-in-patients-with-parkinson-disease-69134https://curecurrent.com/trials/sleep-awake-move-part-ii-69135https://curecurrent.com/trials/pain-in-parkinson-s-disease-with-motor-fluctuations-69136https://curecurrent.com/trials/atomoxetine-treatment-for-cognitive-impairment-in-parkinson-s-disease-atm-cog-69137https://curecurrent.com/trials/tryptophan-depletion-in-pd-patients-treated-with-stn-dbs-69138https://curecurrent.com/trials/foxbionet-pilot-project-save-synuclein-assay-validation-effort-69139https://curecurrent.com/trials/a-study-of-ap-cd-ld-in-fluctuating-parkinson-s-disease-patients-who-completed-in-11-004-69140https://curecurrent.com/trials/autologous-mesenchymal-stem-cell-transplant-for-parkinson-s-disease-69141https://curecurrent.com/trials/drug-interaction-with-genes-in-parkinson-s-disease-69142https://curecurrent.com/trials/open-label-extension-study-with-requip-pr-for-subjects-from-study-rop111528-69143https://curecurrent.com/trials/characterization-of-fecal-microbiome-changes-after-administration-of-prim-dj2727-in-parkinson-s-disease-patients-69144https://curecurrent.com/trials/global-response-during-infusion-of-a-gel-with-levodopa-carbidopa-69145https://curecurrent.com/trials/transdermal-rotigotine-user-surveillance-study-69146https://curecurrent.com/trials/efficacy-and-safety-study-of-inhaled-cvt-301-in-parkinson-s-disease-patients-for-treatment-of-off-episodes-69147https://curecurrent.com/trials/a-comparison-of-voice-amplifiers-and-personal-communication-systems-in-individuals-with-parkinson-s-disease-69148https://curecurrent.com/trials/a-phase-iii-randomised-double-blind-placebo-controlled-parallel-group-study-of-six-months-treatment-with-ropinirole-pr-a-69149https://curecurrent.com/trials/pd-1-antibody-expressing-mesocar-t-cells-for-mesothelin-positive-advanced-solid-tumor-69150https://curecurrent.com/trials/effects-of-feet-mechanical-stimulation-on-cardiovascular-autonomic-profile-and-inflammation-in-parkinson-s-disease-69151https://curecurrent.com/trials/compare-rates-of-agreement-between-clinical-diagnosis-and-visual-assessment-of-datscan-images-in-non-caucasian-and-cauca-69152https://curecurrent.com/trials/efficacy-of-voice-treatment-for-parkinson-s-disease-69153https://curecurrent.com/trials/accuracy-of-markerless-motion-capture-evaluation-in-parkinson-s-disease-after-dbs-69154https://curecurrent.com/trials/protocol-mental-practice-combined-with-physical-practice-of-gait-in-parkinson-s-disease-69155https://curecurrent.com/trials/long-term-safety-and-effectiveness-of-levodopa-carbidopa-intestinal-gel-infusion-69156https://curecurrent.com/trials/sarizotan-hc1-in-patients-with-parkinson-s-disease-suffering-from-treatment-associated-dyskinesia-69157https://curecurrent.com/trials/pre-c-i-s-a-fall-prevention-and-promotion-of-active-and-healthy-aging-69158https://curecurrent.com/trials/prevalence-of-abnormal-postures-in-parkinson-s-disease-69159https://curecurrent.com/trials/study-for-the-early-diagnosis-of-parkinson-s-disease-69160https://curecurrent.com/trials/investigation-of-the-psychometric-properties-of-the-squares-test-in-measuring-hand-function-in-parkinson-s-disease-69161https://curecurrent.com/trials/parkinson-s-autonomic-responses-to-treadmill-walking-69162https://curecurrent.com/trials/study-to-assess-pharmacokinetics-of-accordion-pill-carbidopa-levodopa-compared-to-immediate-release-carbidopa-levodopa-i-69163https://curecurrent.com/trials/music-role-in-pd-rehabilitation-69164https://curecurrent.com/trials/reducing-dyskinesia-in-parkinson-s-disease-with-omega-3-fatty-acids-69165https://curecurrent.com/trials/imaging-neuromelanin-and-iron-in-dystonia-parkinsonism-69166https://curecurrent.com/trials/preventing-falls-and-participation-restrictions-in-neurological-diseases-69167https://curecurrent.com/trials/changes-in-functional-performance-in-individuals-with-parkinson-s-disease-following-2-month-physiotherapy-intervention-69168https://curecurrent.com/trials/controlled-trial-with-deep-brain-stimulation-in-patients-with-early-parkinson-s-disease-69169https://curecurrent.com/trials/effects-of-droxidopa-when-measuring-gait-speed-kyphosis-and-functional-reach-in-parkinson-s-disease-69170https://curecurrent.com/trials/long-term-training-effects-of-rhythmic-auditory-stimulation-on-gait-in-patients-with-parkinson-s-disease-69171https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-18-to-24mg-day-ropinirole-controlled-release-cr-tablets-in-early-and-advanced-parkin-69172https://curecurrent.com/trials/a-fixed-dose-study-of-ropinirole-prolonged-release-as-adjunctive-treatment-in-patients-with-advanced-parkinson-s-disease-69173https://curecurrent.com/trials/a-fixed-dose-dose-response-study-for-ropinirole-prolonged-release-in-patients-with-early-stage-parkinson-s-disease-69174https://curecurrent.com/trials/a-study-conducted-in-healthy-subjects-to-demonstrate-bioequivalence-between-ropinirole-prolonged-release-tablets-manufac-69175https://curecurrent.com/trials/ropinirole-pr-pharmacokinetics-study-among-chinese-healthy-subjects-69176https://curecurrent.com/trials/dbs-in-the-treatment-of-intractable-movement-disorders-69177https://curecurrent.com/trials/11c-pib-pet-ct-in-patients-with-parkinson-s-disease-and-parkinsonian-dementia-syndromes-69178https://curecurrent.com/trials/can-dance-therapy-improve-motor-learning-in-parkinson-s-disease-pd-69179https://curecurrent.com/trials/evaluation-of-efficacy-of-musical-treadmill-in-pd-rehabilitation-69180https://curecurrent.com/trials/intraoperative-analysis-of-reward-and-impulsivity-in-the-basal-ganglia-69181https://curecurrent.com/trials/effects-of-yoga-on-parkinson-s-disease-69182https://curecurrent.com/trials/combined-stimulation-of-stn-and-snr-for-dysphagia-in-parkinson-s-disease-69183https://curecurrent.com/trials/individualized-precise-localization-of-rtms-on-primary-motor-area-69184https://curecurrent.com/trials/a-study-to-assess-the-efficacy-safety-and-tolerability-of-abt-slv187-monotherapy-in-subjects-with-advanced-parkinson-s-d-69185https://curecurrent.com/trials/relationship-between-dopaminergic-asymmetric-degeneration-and-attentional-resources-in-parkinson-s-disease-69186https://curecurrent.com/trials/chinese-pd-snca-registry-69187https://curecurrent.com/trials/chinese-pd-gba-registry-69188https://curecurrent.com/trials/chinese-pd-lrrk2-registry-69189https://curecurrent.com/trials/effect-mechanism-investigation-of-a-non-invasive-stimulation-device-for-rapid-alleviation-of-parkinson-s-disease-symptom-69190https://curecurrent.com/trials/feasibility-and-optimization-of-a-cognitive-intervention-for-parkinson-disease-69191https://curecurrent.com/trials/beam-walking-across-the-lifespan-for-falls-prediction-69192https://curecurrent.com/trials/a-clinical-study-of-irl790-in-patients-with-parkinson-s-disease-experiencing-levodopa-induced-dyskinesia-69193https://curecurrent.com/trials/mri-study-of-brain-activity-in-healthy-adults-and-individuals-with-parkinsonism-and-rapid-eye-movement-disorder-69194https://curecurrent.com/trials/identification-of-clinically-relevant-markers-of-deep-brain-stimulation-electrode-impedance-69195https://curecurrent.com/trials/effects-of-resistant-starch-on-bowel-habits-fecal-short-chain-fatty-acids-and-gut-microbiota-in-parkinson-disease-69196https://curecurrent.com/trials/tdcs-in-parkinson-s-disease-with-depression-69197https://curecurrent.com/trials/study-of-subthalamic-brain-stimulation-in-parkinson-disease-pd-69198https://curecurrent.com/trials/chinese-eopd-registry-69199https://curecurrent.com/trials/the-profile-of-the-depression-and-it-s-intervention-strategy-in-patients-with-parkinson-s-disease-in-china-69200https://curecurrent.com/trials/the-use-of-sensory-or-motor-cues-using-electrical-stimulation-to-reduce-gait-freezing-in-patients-with-parkinson-disease-69201https://curecurrent.com/trials/lrrk2-and-other-novel-exosome-proteins-in-parkinson-s-disease-69202https://curecurrent.com/trials/chinese-fpd-registry-69203https://curecurrent.com/trials/dexmedetomidine-on-basal-ganglia-neuronal-activity-in-parkinson-s-disease-69204https://curecurrent.com/trials/improving-posture-in-parkinson-s-patients-through-home-based-training-and-biofeedback-69205https://curecurrent.com/trials/deep-rtms-in-parkinson-disease-pain-syndromes-69206https://curecurrent.com/trials/cholinergic-augmentation-in-frequently-falling-subjects-with-parkinson-s-disease-69207https://curecurrent.com/trials/parkinson-s-disease-biomarker-program-69208https://curecurrent.com/trials/pharmacomri-of-parkinson-disease-69209https://curecurrent.com/trials/datscan-with-prototype-collimator-69210https://curecurrent.com/trials/evaluation-of-ronnie-gardiner-method-in-individuals-with-parkinson-s-disease-69211https://curecurrent.com/trials/exergaming-in-upper-extremities-for-persons-with-parkinson-s-disease-69212https://curecurrent.com/trials/efficacy-of-ethnodyne-visio-in-parkinson-s-disease-69213https://curecurrent.com/trials/study-of-glycopyrrolate-for-moderate-to-severe-sialorrhea-in-parkinson-s-disease-69214https://curecurrent.com/trials/sleep-homeostasis-in-parkinson-s-disease-69215https://curecurrent.com/trials/freezing-of-gait-clinical-cognitive-and-imaging-features-69216https://curecurrent.com/trials/efficacy-and-safety-proof-of-concept-study-in-patients-with-parkinson-s-disease-and-end-of-dose-wearing-off-compoc-69217https://curecurrent.com/trials/degenerative-nigrostriatal-dysfunction-in-drug-induced-parkinsonism-69218https://curecurrent.com/trials/shanghai-parkinson-s-study-69219https://curecurrent.com/trials/observational-study-with-neupro-to-evaluate-the-patient-s-perception-of-pain-associated-with-parkinson-s-disease-69220https://curecurrent.com/trials/rotigotine-versus-placebo-a-study-to-evaluate-the-efficacy-in-advanced-stage-idiopathic-parkinson-s-disease-patients-69221https://curecurrent.com/trials/sarizotan-in-participants-with-parkinson-s-disease-suffering-from-treatment-associated-dyskinesia-69222https://curecurrent.com/trials/sildenafil-viagra-for-the-treatment-of-dyskinesias-in-parkinson-s-disease-69223https://curecurrent.com/trials/safety-tolerability-pk-and-pd-study-of-neu-120-in-the-treatment-of-levodopa-induced-dyskinesia-69224https://curecurrent.com/trials/clinical-study-to-investigate-the-efficacy-and-safety-of-two-dose-levels-of-nt-201-versus-placebo-in-treating-chronic-tr-69225https://curecurrent.com/trials/speed-of-processing-training-in-patients-with-parkinson-s-disease-and-healthy-older-adults-69226https://curecurrent.com/trials/effect-of-an-apomorphine-pump-on-the-quality-of-sleep-in-parkinson-s-disease-patients-pomprenelle-69227https://curecurrent.com/trials/the-safety-of-remote-dbs-programming-system-69228https://curecurrent.com/trials/action-observation-theraphy-in-parkinson-s-disease-69229https://curecurrent.com/trials/the-t-rkish-version-of-the-freezing-of-gait-questionnaire-69230https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-pxt002331-foliglurax-in-reducing-levodopa-induced-dyskinesia-a-69231https://curecurrent.com/trials/a-study-of-kw-6356-in-subjects-with-early-parkinson-s-disease-69232https://curecurrent.com/trials/exploration-of-the-reward-system-by-functional-mri-in-parkinson-s-disease-patients-with-and-without-rem-sleep-behavior-d-69233https://curecurrent.com/trials/evaluate-the-effectiveness-and-safety-of-variable-frequency-stimulation-compared-with-constant-frequency-stimulation-for-69234https://curecurrent.com/trials/volumetric-bone-mineral-density-and-it-s-relationship-with-osteoporotic-fractures-in-parkinson-s-disease-69235https://curecurrent.com/trials/effect-of-robot-assisted-gait-training-on-gait-automaticity-in-patients-with-parkinson-s-disease-69236https://curecurrent.com/trials/a-mobile-application-for-telerehabilitation-in-parkinson-s-disease-69237https://curecurrent.com/trials/amyloid-beta-and-cognition-in-parkinson-disease-69238https://curecurrent.com/trials/effect-of-acetylcholinesterase-inhibitors-on-the-gait-of-the-patients-with-parkinson-disease-69239https://curecurrent.com/trials/transcranial-duplex-scanning-and-single-photon-emission-computer-tomography-spect-in-parkinsonian-syndromes-69240https://curecurrent.com/trials/the-essential-tremor-et-and-parkinson-disease-pd-tremor-acute-stimulation-study-69241https://curecurrent.com/trials/comparing-the-effectiveness-of-shotokan-karate-vs-tai-chi-on-balance-and-quality-of-life-in-parkinson-s-disease-69242https://curecurrent.com/trials/the-impact-of-standard-medical-care-dopamine-and-practice-on-postural-motor-learning-in-parkinson-s-disease-69243https://curecurrent.com/trials/exogenous-effects-of-standard-medical-care-dopamine-on-motor-learning-of-an-upper-limb-task-in-parkinson-disease-69244https://curecurrent.com/trials/ipratropium-spray-for-drooling-saliva-in-parkinson-s-disease-69245https://curecurrent.com/trials/neural-signatures-of-parkinson-s-disease-69246https://curecurrent.com/trials/kinesia-360-parkinson-s-monitoring-study-69247https://curecurrent.com/trials/behavioural-addictions-occurring-during-a-dopaminergic-treatment-prescribe-under-parkinson-s-disease-study-of-the-psycho-69248https://curecurrent.com/trials/arousal-response-tool-for-neurological-disease-69249https://curecurrent.com/trials/feasibility-of-continuous-sleep-recording-in-patients-undergoing-deep-brain-stimulation-for-parkinson-s-disease-69250https://curecurrent.com/trials/ads-5102-for-the-treatment-of-levodopa-induced-dyskinesia-ease-lid-study-69251https://curecurrent.com/trials/clinical-profile-of-parkinson-s-disease-in-patients-with-hepatitis-c-infection-69252https://curecurrent.com/trials/dns-7801-vs-placebo-in-parkinson-s-disease-69253https://curecurrent.com/trials/quantification-of-the-antidyskinetic-effect-of-amantadine-and-topiramate-in-parkinson-s-disease-69254https://curecurrent.com/trials/help-seeking-for-health-problems-in-people-with-parkinson-s-69255https://curecurrent.com/trials/mirabegron-for-treatment-of-overactive-bladder-symptoms-in-patients-with-parkinson-s-disease-69256https://curecurrent.com/trials/improving-functional-disability-and-cognition-in-parkinson-disease-randomized-controlled-trial-69257https://curecurrent.com/trials/a-single-dose-2-period-2-treatment-2-way-crossover-bioequivalency-study-of-ropinirole-0-25-mg-tablets-under-fed-conditio-69258https://curecurrent.com/trials/virtual-reality-can-be-used-to-improve-balance-reducing-dynamic-falls-in-those-with-parkinson-s-disease-69259https://curecurrent.com/trials/vibrotactile-stimulation-in-parkinson-s-disease-69260https://curecurrent.com/trials/a-single-dose-2-period-2-treatment-2-way-crossover-bioequivalency-study-of-ropinirole-0-25-mg-tablets-und-fasted-conditi-69261https://curecurrent.com/trials/local-fields-potentials-recorded-from-deep-brain-stimulating-electrodes-69262https://curecurrent.com/trials/study-evaluating-nelotanserin-for-treatment-of-visual-hallucinations-in-subjects-with-lewy-body-dementia-69263https://curecurrent.com/trials/efficacy-and-safety-study-of-ads-5102-in-pd-patients-with-levodopa-induced-dyskinesia-69264https://curecurrent.com/trials/behavioral-therapy-to-treat-urinary-symptoms-in-parkinson-disease-69265https://curecurrent.com/trials/evaluation-of-the-protective-role-of-the-l-dopa-against-age-related-macular-degeneration-in-parkinson-s-patients-69266https://curecurrent.com/trials/a-randomized-trial-to-evaluate-ampyra-for-gait-impairment-in-parkinson-s-disease-69267https://curecurrent.com/trials/task-priority-effects-on-postural-suprapostural-task-in-patients-with-parkinson-s-disease-69268https://curecurrent.com/trials/effects-of-a-dance-and-walking-program-for-people-with-parkinson-s-disease-69269https://curecurrent.com/trials/aquatic-therapy-for-freezing-of-gait-in-parkinson-s-disease-patients-69270https://curecurrent.com/trials/the-clinical-profile-of-parkinson-disease-in-egypt-69271https://curecurrent.com/trials/telehealth-allied-health-care-with-people-who-have-parkinson-s-disease-living-in-rural-nevada-and-wyoming-69272https://curecurrent.com/trials/neuroimaging-of-dystonia-69273https://curecurrent.com/trials/sagene-2014-parkinson-s-disease-and-erectile-dysfunction-69274https://curecurrent.com/trials/long-term-vesicular-monoamine-transporter-ii-imaging-and-clinical-assessment-of-parkinson-s-disease-progression-69275https://curecurrent.com/trials/extended-release-amantadine-safety-and-efficacy-study-in-levodopa-induced-dyskinesia-eased-study-69276https://curecurrent.com/trials/a-multidisciplinary-approach-to-manage-gait-difficulty-in-parkinson-patients-69277https://curecurrent.com/trials/guided-self-help-for-depression-in-parkinson-s-disease-69278https://curecurrent.com/trials/providing-specialty-care-to-individuals-with-parkinsonism-directly-in-their-homes-via-web-based-video-conferencing-a-com-69279https://curecurrent.com/trials/effects-of-dexmedetomidine-on-activity-in-the-subthalamic-nucleus-69280https://curecurrent.com/trials/validation-of-haguide-software-module-accuracy-in-mapping-stn-boundaries-in-parkinson-s-disease-patients-who-underwent-d-69281https://curecurrent.com/trials/pilot-study-evaluating-safety-of-unilateral-gamma-knife-subthalamotomy-for-parkinson-s-disease-69282https://curecurrent.com/trials/treating-h-pylori-in-parkinson-s-patients-with-motor-fluctuations-69283https://curecurrent.com/trials/effects-of-nordic-walking-in-parkinson-disease-patients-69284https://curecurrent.com/trials/study-to-assess-the-safety-and-effects-of-autologous-adipose-derived-svf-cells-in-patients-with-parkinson-s-disease-69285https://curecurrent.com/trials/progressive-modular-rebalancing-rmp-system-rehabilitation-combined-with-sensory-cues-for-rehabilitation-of-patients-with-69286https://curecurrent.com/trials/a-pharmacokinetic-study-of-levodopa-and-carbidopa-intestinal-gel-in-subjects-with-advanced-parkinson-s-disease-69287https://curecurrent.com/trials/feasibility-and-effectiveness-of-virtual-reality-use-of-body-weight-support-treadmill-training-in-parkinson-s-disease-69288https://curecurrent.com/trials/double-blind-placebo-surgery-trial-for-treatment-of-parkinson-s-disease-69289https://curecurrent.com/trials/electro-acupuncture-for-gait-and-balance-in-parkinson-s-disease-69290https://curecurrent.com/trials/predictors-of-gait-improvement-in-patients-with-parkinson-s-disease-after-rehabilitation-69291https://curecurrent.com/trials/treatment-of-executive-dysfunction-in-parkinson-s-disease-69292https://curecurrent.com/trials/exploratory-study-using-nanotechnology-to-detect-biomarkers-of-parkinson-s-disease-from-exhaled-breath-69293https://curecurrent.com/trials/tremor-monitoring-device-69294https://curecurrent.com/trials/development-and-evaluation-of-a-guide-to-help-people-with-parkinson-s-and-their-caregivers-to-self-manage-falling-69295https://curecurrent.com/trials/non-motors-aspects-in-de-novo-parkinson-s-disease-69296https://curecurrent.com/trials/visual-function-during-gait-in-parkinson-s-disease-impact-of-cognition-and-response-to-visual-cues-69297https://curecurrent.com/trials/instrumental-or-physical-exercise-rehabilitation-of-balance-in-parkinson-s-disease-iper-pd-69298https://curecurrent.com/trials/impact-of-myotensives-techniques-with-and-without-auto-reeducation-on-the-vital-capacity-forced-by-the-patient-affected-69299https://curecurrent.com/trials/lovastatin-as-a-neuroprotective-treatment-for-early-stage-parkinson-s-disease-69300https://curecurrent.com/trials/effect-of-osteopathic-manipulative-medicine-omm-on-pulmonary-function-and-speech-in-parkinson-s-disease-69301https://curecurrent.com/trials/study-in-parkinson-s-disease-of-exercise-69302https://curecurrent.com/trials/combination-therapy-of-cord-blood-and-g-csf-for-patients-with-brain-injury-or-neurodegenerative-disorders-69303https://curecurrent.com/trials/determining-clinical-profile-of-parkinson-s-disease-among-egyptian-population-69304https://curecurrent.com/trials/pilot-study-to-evaluate-actimyo-measured-activity-in-parkinson-disease-patients-healthy-volunteers-69305https://curecurrent.com/trials/cope-co-morbidities-parkinson-s-disease-and-exercise-69306https://curecurrent.com/trials/convection-enhanced-delivery-to-study-the-pathophysiology-underlying-the-clinical-features-of-parkinson-s-disease-69307https://curecurrent.com/trials/the-effect-of-lesion-characteristics-in-mrgfus-on-tremor-in-essential-tremor-and-parkinson-s-disease-69308https://curecurrent.com/trials/whole-body-periodic-acceleration-on-activity-and-sleep-in-parkinson-s-disease-69309https://curecurrent.com/trials/decrease-in-sense-of-smell-and-associated-cognitive-decline-in-parkinson-s-disease-69310https://curecurrent.com/trials/pilates-as-an-adjuvant-therapy-in-parkinson-disease-69311https://curecurrent.com/trials/pharmacokinetic-of-levodopa-study-in-healthy-males-69312https://curecurrent.com/trials/uncovering-an-electrical-biomarker-for-freezing-of-gait-in-parkinson-s-disease-69313https://curecurrent.com/trials/multi-centre-uk-study-of-the-acetylcholinesterase-inhibitor-donepezil-in-early-dementia-associated-with-parkinson-s-dise-69314https://curecurrent.com/trials/open-label-trial-to-determine-the-long-term-safety-of-safinamide-in-parkinson-s-disease-patients-69315https://curecurrent.com/trials/a-study-to-evaluate-safinamide-s-effect-on-dopamine-and-serotonin-s-availability-by-using-brain-imaging-69316https://curecurrent.com/trials/pramipexole-and-bromocriptine-on-nonmotor-symptoms-of-early-parkinson-s-disease-69317https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-human-neural-stem-cells-for-parkinson-s-disease-patient-69318https://curecurrent.com/trials/a-cross-over-multi-center-trial-to-evaluate-the-diagnostic-efficacy-and-safety-of-123i-nav5001-as-an-imaging-agent-to-ai-69319https://curecurrent.com/trials/memantine-for-treatment-of-cognitive-impairment-in-patients-with-parkinson-s-disease-and-dementia-69320https://curecurrent.com/trials/evaluation-of-the-benefit-provided-by-acupuncture-during-a-surgery-of-deep-brain-stimulation-69321https://curecurrent.com/trials/evaluating-the-influence-of-externally-vs-internally-focused-exercise-on-rehabilitation-in-parkinson-s-disease-69322https://curecurrent.com/trials/online-cognitive-training-in-pd-ms-and-depressed-patients-treated-with-electroconvulsive-therapy-69323https://curecurrent.com/trials/mass-balance-recovery-metabolite-profile-and-metabolite-identification-of-14c-bia-9-1067-69324https://curecurrent.com/trials/sub-thalamic-nucleus-stimulation-in-parkinson-disease-69325https://curecurrent.com/trials/effect-of-melatonin-on-sleep-disturbances-in-patients-with-parkinson-s-disease-69326https://curecurrent.com/trials/a-comparison-of-ropinirole-immediate-release-with-ropinirole-prolonged-release-in-patients-with-advanced-parkinson-s-69327https://curecurrent.com/trials/deep-brain-stimulation-for-parkinson-s-disease-the-globus-pallidus-internus-versus-subthalamic-nucleus-69328https://curecurrent.com/trials/systemic-synuclein-sampling-study-s4-69329https://curecurrent.com/trials/action-observation-plus-sonification-therapeutic-protocol-69330https://curecurrent.com/trials/the-effect-of-a-wearable-cueing-device-on-freezing-of-gait-in-parkinson-s-disease-69331https://curecurrent.com/trials/motion-immune-magnetic-resonance-imaging-mri-69332https://curecurrent.com/trials/study-to-evaluate-syn115-in-parkinson-s-disease-69333https://curecurrent.com/trials/somatosensory-dysfunction-as-the-underlying-mechanism-of-upper-limbs-motor-blocks-in-people-with-parkinson-s-disease-69334https://curecurrent.com/trials/dance-for-people-with-parkinson-s-disease-69335https://curecurrent.com/trials/functional-magnetic-resonance-imaging-fmri-during-deep-brain-stimulation-dbs-to-treat-parkinson-s-disease-69336https://curecurrent.com/trials/neurotransmitter-measurements-using-wincs-during-deep-brain-stimulation-neurosurgery-69337https://curecurrent.com/trials/intranasal-glutathione-in-parkinson-s-disease-69338https://curecurrent.com/trials/the-effects-of-nicotine-chewing-gum-in-parkinson-s-disease-69339https://curecurrent.com/trials/safety-pharmacokinetics-and-efficacy-study-of-cvt-301-inpatients-with-parkinson-s-disease-and-off-episodes-69340https://curecurrent.com/trials/improving-dynamic-balance-and-gait-adaptability-using-treadmill-training-69341https://curecurrent.com/trials/the-impact-of-three-distinct-exercise-types-on-fatigue-anxiety-and-depression-in-parkinson-s-disease-69342https://curecurrent.com/trials/efficacy-of-a-non-invasive-device-for-alleviation-of-parkinson-s-disease-symptoms-69343https://curecurrent.com/trials/effects-of-ecological-rythmic-acoustic-stimulation-e-ras-on-motor-skills-in-individuals-with-parkinson-s-disease-69344https://curecurrent.com/trials/efficacy-phase-iia-study-of-cvxl-0107-in-advanced-parkinson-s-disease-69345https://curecurrent.com/trials/dat-spect-and-procedural-motor-skills-in-parkinson-s-disease-69346https://curecurrent.com/trials/mobile-health-technology-to-promote-physical-activity-in-persons-with-parkinson-disease-69347https://curecurrent.com/trials/laser-light-cues-for-gait-freezing-in-parkinson-s-disease-69348https://curecurrent.com/trials/assessment-of-actigraphy-procedures-on-the-initiation-of-an-apomorphine-treatment-delivered-through-a-pump-to-patients-w-69349https://curecurrent.com/trials/development-and-research-of-an-individualized-intelligent-platform-for-rehabilitaion-in-parkinson-s-disease-69350https://curecurrent.com/trials/acupuncture-in-the-treatment-of-fatigue-in-parkinson-s-disease-69351https://curecurrent.com/trials/a-rehabilitative-approach-in-patients-with-parkinson-s-disease-69352https://curecurrent.com/trials/acp-103-to-treat-parkinson-s-disease-69353https://curecurrent.com/trials/how-the-loss-of-dopamine-and-dopamine-restoring-medicines-affect-movement-performance-69354https://curecurrent.com/trials/sequence-effect-in-parkinson-s-disease-69355https://curecurrent.com/trials/cell-studies-of-parkinson-s-disease-69356https://curecurrent.com/trials/evaluation-of-directional-recording-and-stimulation-using-spiderstn-69357https://curecurrent.com/trials/motor-cortex-reward-signaling-in-parkinson-disease-69358https://curecurrent.com/trials/relationship-of-dopamine-to-cognitive-function-in-parkinson-s-disease-69359https://curecurrent.com/trials/gene-analysis-of-parkinson-s-disease-69360https://curecurrent.com/trials/measures-of-motor-impairment-in-early-parkinson-s-disease-69361https://curecurrent.com/trials/genetic-analysis-of-parkinson-s-disease-69362https://curecurrent.com/trials/investigating-the-safety-of-srtms-in-the-treatment-of-parkinson-s-disease-69363https://curecurrent.com/trials/evaluation-of-directional-stimulation-during-the-implantation-of-deep-brain-stimulation-dbs-leads-69364https://curecurrent.com/trials/motor-skill-learning-in-people-with-parkinson-s-disease-69365https://curecurrent.com/trials/lisuride-patch-to-treat-parkinson-s-disease-69366https://curecurrent.com/trials/telemedicine-intervention-to-improve-physical-function-69367https://curecurrent.com/trials/wuling-powder-for-the-treatment-and-underlying-mechanism-of-depressive-symptoms-in-patients-with-parkinson-s-disease-69368https://curecurrent.com/trials/real-time-fmri-neurofeedback-for-treatment-of-parkinson-s-disease-69369https://curecurrent.com/trials/combined-stimulation-of-stn-and-snr-for-resistant-freezing-of-gait-in-parkinson-s-disease-69370https://curecurrent.com/trials/follow-up-study-to-assess-a-second-boost-immunization-with-affitope-pd01a-with-regard-to-safety-and-clinical-activity-af-69371https://curecurrent.com/trials/managing-changes-in-life-after-deep-brain-stimulation-for-parkinson-s-disease-69372https://curecurrent.com/trials/quantification-of-dopamine-active-transporter-dat-in-humans-validation-of-a-new-radiophamaceutical-the-18f-lbt-999-69373https://curecurrent.com/trials/deep-brain-stimulation-dbs-for-early-stage-parkinson-s-disease-pd-69374https://curecurrent.com/trials/ubiquinol-in-parkinson-s-disease-safety-tolerability-and-effects-upon-oxidative-damage-and-mitochondrial-biomarkers-69375https://curecurrent.com/trials/a-study-of-safety-and-efficacy-of-pimavanserin-acp-103-in-patients-with-parkinson-s-disease-psychosis-69376https://curecurrent.com/trials/study-of-dysarthria-swallowing-disorders-and-respiratory-in-parkinson-s-disease-69377https://curecurrent.com/trials/a-study-to-evaluate-fixed-dose-carbidopa-levodopa-entacapone-versus-immediate-release-carbidopa-levodopa-69378https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-pimavanserin-acp-103-in-patients-with-parkinson-s-disease-psychosis-69379https://curecurrent.com/trials/parkinson-s-diseases-susceptibility-genes-and-pesticides-69380https://curecurrent.com/trials/cardiovascular-events-in-parkinson-s-disease-patients-69381https://curecurrent.com/trials/dopaminergic-modulation-of-declarative-memory-69382https://curecurrent.com/trials/assessment-of-three-dimensional-vision-alteration-in-parkinson-disease-69383https://curecurrent.com/trials/education-in-therapy-of-parkinson-s-disease-69384https://curecurrent.com/trials/lrrk2-mutation-and-parkinson-s-disease-69385https://curecurrent.com/trials/non-invasive-measurement-of-brain-oxygen-levels-in-people-with-subthalamic-deep-brain-stimulators-69386https://curecurrent.com/trials/apomorphine-in-parkinson-s-disease-patients-with-visual-hallucinations-69387https://curecurrent.com/trials/comparison-of-the-incidence-of-dyskinesia-in-parkinson-s-disease-who-were-treated-with-amantadine-or-dopamine-agonist-69388https://curecurrent.com/trials/temporal-relationship-between-motor-fluctuations-and-nonmotor-fluctuations-69389https://curecurrent.com/trials/swallowing-and-breathing-exercises-for-dysphagia-in-parkinson-disease-69390https://curecurrent.com/trials/hub-and-spoke-comparative-outcomes-for-parkinson-s-disease-treated-with-deep-brain-stimulation-69391https://curecurrent.com/trials/investigating-therapies-for-freezing-of-gait-69392https://curecurrent.com/trials/implantable-systems-performance-registry-69393https://curecurrent.com/trials/expanded-access-of-pimavanserin-for-patients-with-pd-psychosis-69394https://curecurrent.com/trials/safety-and-efficacy-study-of-human-esc-derived-neural-precursor-cells-in-the-treatment-of-parkinson-s-disease-69395https://curecurrent.com/trials/effect-of-food-on-opicapone-69396https://curecurrent.com/trials/cholinergic-nicotinic-receptors-and-cognition-in-pd-69397https://curecurrent.com/trials/rtms-for-motor-and-mood-symptoms-of-parkinson-s-disease-69398https://curecurrent.com/trials/risk-factors-for-progressive-supranuclear-palsy-psp-69399https://curecurrent.com/trials/mild-cognitive-impairment-in-parkinson-s-disease-69400https://curecurrent.com/trials/efficacy-and-tolerability-of-nebicapone-in-parkinson-s-disease-patients-with-wearingoff-phenomenon-69401https://curecurrent.com/trials/impact-of-rehabilitation-in-quality-of-life-in-pd-69402https://curecurrent.com/trials/the-effects-of-treadmill-training-with-visual-and-auditory-cues-on-gait-parameters-in-parkinsonian-patients-in-advanced-69403https://curecurrent.com/trials/effectiveness-of-intensive-rehabilitation-in-advanced-stages-of-parkinson-s-disease-69404https://curecurrent.com/trials/handwriting-rehabilitation-in-parkinson-disease-69405https://curecurrent.com/trials/rotigotine-effect-on-nocturnal-hypokinesia-compares-to-placebo-control-a-quantitative-assessment-by-wearable-sensors-69406https://curecurrent.com/trials/effect-of-bia-6-512-at-steady-state-on-the-levodopa-pharmacokinetics-with-a-single-dose-of-levodopa-benserazide-200-50-m-69407https://curecurrent.com/trials/magnetic-resonance-imaging-in-the-diagnosis-of-parkinsonian-syndromes-69408https://curecurrent.com/trials/pharmacokinetic-profile-of-bia-6-512-in-healthy-elderly-subjects-versus-healthy-young-subjects-69409https://curecurrent.com/trials/effect-of-bia-6-512-at-steady-state-on-the-levodopa-pharmacokinetics-69410https://curecurrent.com/trials/effects-of-carbidopa-levodopa-entacapone-on-motor-function-and-quality-of-life-in-patients-with-parkinson-s-disease-69411https://curecurrent.com/trials/blood-lactate-concentrations-with-and-without-exercise-in-parkinson-s-disease-and-multiple-sclerosis-patients-69412https://curecurrent.com/trials/study-to-compare-the-effect-of-treatment-with-carbidopa-levodopa-entacapone-on-the-quality-of-life-of-patients-with-park-69413https://curecurrent.com/trials/effect-of-food-on-bia-6-512-trans-resveratrol-69414https://curecurrent.com/trials/tolerability-and-steady-state-pharmacokinetics-of-bia-6-512-69415https://curecurrent.com/trials/pharmacokinetics-of-rising-single-doses-of-bia-6-512-and-their-effect-on-the-levodopa-pharmacokinetics-69416https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-pf-06649751-in-parkinson-s-disease-69417https://curecurrent.com/trials/tolerability-safety-and-pharmacokinetics-of-four-single-doses-of-bia-6-512-trans-resveratrol-and-their-effect-on-the-lev-69418https://curecurrent.com/trials/respiratory-kinematics-of-cough-in-healthy-older-adults-and-parkinson-s-disease-69419https://curecurrent.com/trials/investigational-parkinson-s-disease-in-patients-not-well-controlled-on-l-dopa-69420https://curecurrent.com/trials/an-open-label-continuation-study-evaluating-the-long-term-safety-of-extended-release-ropinirole-xl-formerly-cr-in-parkin-69421https://curecurrent.com/trials/caffeine-as-a-therapy-for-parkinson-s-disease-69422https://curecurrent.com/trials/a-study-of-ly3154207-in-healthy-participants-and-participants-with-parkinson-s-disease-69423https://curecurrent.com/trials/variable-frequency-stimulation-of-subthalamic-nucleus-for-freezing-of-gait-in-parkinson-s-disease-69424https://curecurrent.com/trials/singing-in-groups-for-parkinson-s-disease-a-pilot-study-of-group-singing-therapy-for-pd-related-voice-speech-impairment-69425https://curecurrent.com/trials/dance-exercise-as-novel-complementary-therapy-for-parkinson-s-disease-69426https://curecurrent.com/trials/long-term-safety-study-of-kw-6500-in-patients-with-parkinson-s-disease-69427https://curecurrent.com/trials/extended-long-term-safety-study-of-kw-6500-69428https://curecurrent.com/trials/incobotulinum-toxin-a-xeomin-for-troublesome-sialorrhea-in-parkinson-s-disease-pd-parkinsonism-69429https://curecurrent.com/trials/safety-and-efficacy-of-botulinuma-toxin-botoxa-for-treatment-of-neurogenic-bladder-of-parkinson-s-disease-69430https://curecurrent.com/trials/translation-and-validation-of-bela-p-k-for-qol-evaluation-in-pd-patients-69431https://curecurrent.com/trials/placebo-controlled-double-blind-crossover-comparative-study-of-kw-6500-69432https://curecurrent.com/trials/motor-non-motor-and-genetic-determinants-of-progression-in-parkinson-s-disease-a-mexican-multicenter-cohort-study-69433https://curecurrent.com/trials/parkinsonics-a-controlled-study-of-group-singing-in-parkinson-disease-69434https://curecurrent.com/trials/effect-of-levodopa-on-postural-motor-learning-in-parkinson-disease-69435https://curecurrent.com/trials/motor-control-during-rapid-eye-movement-rem-sleep-behaviour-disorder-69436https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-afq056-in-reducing-moderate-to-severe-l-dopa-induced-dyskinesias-in-patients-wi-69437https://curecurrent.com/trials/movement-disorder-quantification-algorithm-development-69438https://curecurrent.com/trials/evaluation-of-the-role-of-the-noradrenergic-system-in-pain-perception-in-parkinson-s-disease-69439https://curecurrent.com/trials/remote-access-to-care-everywhere-for-parkinson-disease-69440https://curecurrent.com/trials/piloting-a-novel-mobile-cognitive-tracking-and-training-tool-for-patients-with-parkinson-s-disease-pd-69441https://curecurrent.com/trials/transcutaneous-electric-nerve-stimulation-in-sleep-of-patients-with-parkinson-s-disease-69442https://curecurrent.com/trials/virtual-reality-in-parkinson-disease-69443https://curecurrent.com/trials/expiratory-muscle-training-for-persons-with-neurodegenerative-disease-69444https://curecurrent.com/trials/a-trial-of-18f-av-133-positron-emission-tomography-pet-imaging-to-differentiate-subjects-with-parkinson-s-disease-pd-fro-69445https://curecurrent.com/trials/evolution-of-rbd-in-pd-69446https://curecurrent.com/trials/incobotulinum-toxin-a-for-sialorrhea-in-parkinson-s-disease-pd-parkinsonism-and-amyotrophic-lateral-sclerosis-als-69447https://curecurrent.com/trials/azilect-antidepressant-chart-review-69448https://curecurrent.com/trials/a-study-to-assess-the-effect-of-repeat-doses-of-gsk962040-on-the-pharmacokinetics-of-l-dopa-in-subjects-with-parkinson-s-69449https://curecurrent.com/trials/erythromycin-in-parkinson-s-disease-69450https://curecurrent.com/trials/computerized-cognitive-behavioral-therapy-trial-for-insomnia-in-parkinson-disease-69451https://curecurrent.com/trials/subthalamotomy-by-exablate-transcranial-system-to-treat-motor-features-of-parkinson-s-disease-69452https://curecurrent.com/trials/a-study-of-the-safety-and-tolerability-of-a-single-dose-administration-of-cvt-301-levodopa-inhalation-powder-69453https://curecurrent.com/trials/effectiveness-of-antidepressant-treatment-for-depression-in-people-with-parkinson-s-disease-69454https://curecurrent.com/trials/connect-parkinson-connecting-individuals-with-parkinson-disease-to-specialists-in-their-homes-69455https://curecurrent.com/trials/behavioural-addiction-and-genetics-in-parkinson-s-disease-69456https://curecurrent.com/trials/clinical-effects-of-vitamin-d-repletion-in-patients-with-parkinson-s-disease-69457https://curecurrent.com/trials/freezing-of-gait-in-parkinson-s-disease-69458https://curecurrent.com/trials/sarizotan-in-parkinson-patients-with-l-dopa-induced-dyskinesia-69459https://curecurrent.com/trials/onset-motor-complications-using-requip-cr-ropinirole-controlled-release-as-add-on-therapy-to-l-dopa-in-parkinson-s-69460https://curecurrent.com/trials/clinical-evaluation-of-ropinirole-prolonged-release-extended-release-pr-xr-tablet-for-adjunctive-therapy-to-l-dopa-in-su-69461https://curecurrent.com/trials/effectiveness-of-different-approaches-for-the-rehabilitation-of-gait-in-patients-with-parkinson-s-disease-69462https://curecurrent.com/trials/effects-of-the-mechanical-peripheral-stimulation-for-parkinson-s-disease-rehabilitation-69463https://curecurrent.com/trials/norepinephrine-transporter-blockade-as-a-pathological-biomarker-in-neurogenic-orthostatic-hypotension-69464https://curecurrent.com/trials/evaluation-of-123i-mni-420-and-spect-as-a-marker-of-the-adenosine-a2a-receptor-in-pd-hd-and-healthy-subjects-69465https://curecurrent.com/trials/lubiprostone-as-a-treatment-for-constipation-in-parkinson-s-disease-69466https://curecurrent.com/trials/altropane-spect-imaging-in-patients-with-parkinson-disease-69467https://curecurrent.com/trials/goal-oriented-intervention-in-parkinson-s-disease-69468https://curecurrent.com/trials/understand-fog-in-pd-behavioral-physiology-and-clinical-application-69469https://curecurrent.com/trials/study-of-motor-slowing-in-parkinson-s-disease-by-a-computerized-mental-chronometry-paradigm-69470https://curecurrent.com/trials/pharmacokinetic-profile-of-neupro-patch-administrated-at-2-mg-4-mg-6-mg-and-8-mg-day-weekly-in-patients-with-early-stage-69471https://curecurrent.com/trials/study-of-the-enteric-nervous-system-using-colonic-biopsies-in-parkinson-patients-with-lrrk2-mutation-69472https://curecurrent.com/trials/haptoglobin-and-iron-in-parkinson-s-disease-69473https://curecurrent.com/trials/assessing-cholinergic-innervation-in-parkinson-s-disease-using-the-pet-imaging-marker-18f-fluoroethoxybenzovesamicol-69474https://curecurrent.com/trials/benefit-from-the-chin-down-maneuver-in-the-swallowing-performance-and-self-perception-of-parkinson-s-disease-patients-69475https://curecurrent.com/trials/effect-of-body-suspension-and-tilting-exercises-in-parkinson-s-disease-69476https://curecurrent.com/trials/exercise-for-adults-with-parkinson-disease-69477https://curecurrent.com/trials/effects-of-deep-brain-stimulation-in-parkinson-s-disease-69478https://curecurrent.com/trials/trial-of-exenatide-for-parkinson-s-disease-69479https://curecurrent.com/trials/strength-training-and-different-subtypes-of-parkinson-s-disease-69480https://curecurrent.com/trials/concurrent-dbs-local-field-potential-analysis-and-stimulation-in-a-closed-loop-neuromodulation-device-69481https://curecurrent.com/trials/intestinal-and-nasal-microbiota-of-patients-with-idiopathic-parkinson-s-disease-69482https://curecurrent.com/trials/deep-brain-stimulation-of-the-subthalamic-nucleus-stn-and-cognitive-control-69483https://curecurrent.com/trials/tdcs-for-treatment-of-depression-in-parkinson-s-disease-69484https://curecurrent.com/trials/study-to-assess-the-clinical-benefit-and-safety-of-droxidopa-in-parkinson-s-disease-69485https://curecurrent.com/trials/exercise-intervention-and-dexterity-in-parkinson-69486https://curecurrent.com/trials/study-assessing-tolerability-and-safety-of-affitope-pd03a-in-patients-with-early-parkinson-s-disease-69487https://curecurrent.com/trials/measuring-the-effects-of-continuous-dopaminergic-stimulation-on-nocturnal-movements-in-parkinson-s-disease-69488https://curecurrent.com/trials/nucleus-basalis-deep-brain-stimulation-for-thinking-memory-problems-in-parkinson-s-69489https://curecurrent.com/trials/parkinson-s-disease-patient-study-on-absorption-distribution-metabolism-and-excretion-of-ropinirole-69490https://curecurrent.com/trials/a-study-to-compare-two-dose-strengths-of-cvt-301-levodopa-inhalation-powder-with-an-oral-dose-of-sinemet-carbidopa-levod-69491https://curecurrent.com/trials/battery-preserving-stimulation-patterns-for-deep-brain-stimulation-69492https://curecurrent.com/trials/multiple-ascending-dose-study-of-prx002-in-patients-with-parkinson-s-disease-69493https://curecurrent.com/trials/autonomic-failure-patients-for-rna-blood-sampling-69494https://curecurrent.com/trials/evaluation-of-nalmefene-in-impulse-control-disorders-in-parkinson-s-disease-a-prospective-open-label-study-69495https://curecurrent.com/trials/satisfaction-survey-on-pins-stimulator-system-for-patients-with-parkinson-s-disease-69496https://curecurrent.com/trials/a-post-marketing-observational-study-of-activities-of-daily-living-in-advanced-parkinson-s-disease-patients-with-early-t-69497https://curecurrent.com/trials/evaluate-the-safety-and-effectiveness-of-various-frequency-stimulation-for-patients-with-parkinson-s-disease-69498https://curecurrent.com/trials/impact-of-subthalamic-nucleus-deep-brain-stimulation-on-pain-in-parkinson-disease-69499https://curecurrent.com/trials/clinical-and-economic-impact-of-duodopa-long-term-effectiveness-study-in-advanced-parkinson-s-disease-patients-69500https://curecurrent.com/trials/cognitive-rehabilitation-in-parkinson-s-disease-69501https://curecurrent.com/trials/bradyxplore-phase-ii-bradykinesia-feature-extraction-system-69502https://curecurrent.com/trials/mucuna-pruriens-therapy-in-parkinson-s-disease-69503https://curecurrent.com/trials/physiopathological-study-of-autonomic-failure-in-parkinson-s-disease-69504https://curecurrent.com/trials/stability-and-balance-in-locomotion-through-exercise-69505https://curecurrent.com/trials/prospective-evaluation-of-forceplate-measured-levodopa-induced-dyskinesia-69506https://curecurrent.com/trials/a-phase-i-double-blind-placebo-controlled-first-in-human-single-and-multiple-ascending-oral-dose-safety-tolerability-and-69507https://curecurrent.com/trials/mental-practice-in-parkinson-s-disease-69508https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-safety-and-efficacy-of-rm-131-in-patients-with-parkinson-s-disease-chronic-constipation-69509https://curecurrent.com/trials/levetiracetam-treatment-of-l-dopa-induced-dyskinesias-69510https://curecurrent.com/trials/pilot-study-for-automated-deep-brain-stimulation-programming-69511https://curecurrent.com/trials/subthalamic-nucleus-stimulation-effect-on-gait-symmetry-and-freezing-of-gait-69512https://curecurrent.com/trials/the-effect-of-bia-9-1067-at-steady-state-on-the-levodopa-pharmacokinetics-69513https://curecurrent.com/trials/respiratory-load-magnitude-estimation-in-pd-69514https://curecurrent.com/trials/a-phase-2a-trial-of-epi-743-for-patients-with-parkinson-s-disease-69515https://curecurrent.com/trials/therapeutic-yoga-to-improve-function-in-parkinson-s-disease-69516https://curecurrent.com/trials/neurogenic-dysphonia-dysphagia-registry-69517https://curecurrent.com/trials/psychiatry-study-parkinson-disease-69518https://curecurrent.com/trials/improving-dexterous-skills-in-parkinson-s-disease-69519https://curecurrent.com/trials/tai-chi-for-enhancing-motor-and-cognitive-function-in-parkinson-s-disease-69520https://curecurrent.com/trials/validation-of-a-diagnostic-self-assessment-scale-non-motor-fluctuations-at-the-parkinson-s-patient-69521https://curecurrent.com/trials/timing-of-acute-palliative-care-consultation-in-critically-ill-patients-69522https://curecurrent.com/trials/study-assessing-tolerability-and-safety-and-exploring-the-immunogenicity-and-therapeutic-activity-of-affitope-pd01a-in-p-69523https://curecurrent.com/trials/diagnosis-of-parkinson-s-disease-using-diffusion-magnetic-resonance-imaging-69524https://curecurrent.com/trials/prediction-of-dementia-in-parkinson-s-disease-by-measuring-cerebral-metabolism-with-pet-scan-69525https://curecurrent.com/trials/weight-loss-in-parkinson-s-disease-and-role-of-small-bowel-bacterial-overgrowth-69526https://curecurrent.com/trials/thoracic-spinal-cord-stimulation-as-a-symptomatic-treatment-for-advanced-parkinson-s-disease-69527https://curecurrent.com/trials/the-effect-of-a-motor-cognitive-rehabilitation-on-attention-in-parkinsonian-patients-69528https://curecurrent.com/trials/the-electrophysiological-investigation-of-higher-level-neural-manifestations-of-freezing-of-gait-in-parkinson-s-disease-69529https://curecurrent.com/trials/long-term-study-of-duodopa-levodopa-carbidopa-in-advanced-parkinson-s-health-outcomes-net-economic-impact-69530https://curecurrent.com/trials/effect-of-two-multiple-dose-regimens-of-bia-3-202-on-the-pharmacokinetics-and-motor-response-of-levodopa-and-on-the-eryt-69531https://curecurrent.com/trials/clock-and-narcolepsy-genetic-variants-and-the-effects-of-stalevo-levodopa-carbidopa-entacapone-on-sleep-disorders-in-par-69532https://curecurrent.com/trials/sam-e-for-the-treatment-of-depression-in-patients-with-parkinson-s-disease-69533https://curecurrent.com/trials/telemedicine-program-in-parkinson-s-disease-telepark-69534https://curecurrent.com/trials/evaluating-the-effectiveness-of-neupro-rotigotine-and-l-dopa-combination-therapy-in-patients-with-parkinson-s-disease-69535https://curecurrent.com/trials/evaluation-of-behaviour-in-parkinson-s-disease-normal-values-in-healthy-subjects-69536https://curecurrent.com/trials/evaluation-of-a-personalized-physical-activity-coaching-program-in-parkinson-s-disease-69537https://curecurrent.com/trials/cannabis-and-parkinson-s-disease-tremor-a-natural-history-study-69538https://curecurrent.com/trials/phase-iib-study-of-intranasal-glutathione-in-parkinson-s-disease-69539https://curecurrent.com/trials/efficacy-of-pattern-respiratory-pnf-associated-aerobic-training-on-lung-volumes-and-6mwt-test-in-parkinson-individuals-69540https://curecurrent.com/trials/orthotics-and-parkinson-s-disease-the-acute-and-long-term-effects-of-increased-somatosensory-feedback-69541https://curecurrent.com/trials/lateral-postural-inclination-in-parkinson-s-disease-involvement-of-the-basal-ganglia-69542https://curecurrent.com/trials/pharmacokinetics-of-bia-9-1067-in-healthy-japanese-and-caucasian-subjects-69543https://curecurrent.com/trials/pet-mr-imaging-in-patients-with-short-and-long-standing-parkinson-s-disease-69544https://curecurrent.com/trials/optimization-of-fmri-for-the-study-of-basal-ganglia-activation-in-parkinson-s-disease-69545https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-interaction-between-bia-3-202-and-levodopa-benserazide-69546https://curecurrent.com/trials/exploration-of-mesocorticolimbic-pathway-in-impulse-control-disorders-in-parkinson-s-disease-study-using-tensor-diffusio-69547https://curecurrent.com/trials/comparison-of-two-rehabilitation-programs-in-patients-with-mild-to-moderate-parkinson-s-disease-69548https://curecurrent.com/trials/parkinsonian-brain-repair-using-human-stem-cells-69549https://curecurrent.com/trials/follow-up-study-for-treatment-of-parkinson-s-disease-with-deep-brain-stimulation-69550https://curecurrent.com/trials/effects-of-transcranial-direct-current-stimulation-on-fine-motor-skills-in-parkinson-s-disease-a-pilot-study-69551https://curecurrent.com/trials/monitoring-brain-waves-in-response-to-visual-and-or-auditory-stimulation-in-parkinson-s-disease-patients-69552https://curecurrent.com/trials/efficacy-and-safety-of-melatonin-pr-and-clonazepam-in-patients-with-rem-sleep-behavior-disorder-in-parkinson-disease-69553https://curecurrent.com/trials/a-randomized-controlled-pilot-trial-comparing-irish-set-dancing-to-usual-care-for-people-with-parkinson-s-disease-69554https://curecurrent.com/trials/how-does-stn-dbs-influence-emotional-conflict-decision-in-parkinson-s-disease-a-eeg-study-69555https://curecurrent.com/trials/virtual-reality-effects-on-functional-capacity-and-quality-of-life-of-people-with-parkinson-s-disease-69556https://curecurrent.com/trials/a-study-to-compare-plasma-levels-of-levodopa-carbidopa-and-entacapone-after-trigel-or-duodopa-infusion-in-pd-patients-69557https://curecurrent.com/trials/rasagiline-as-add-on-to-dopamine-agonists-in-the-treatment-of-parkinson-s-disease-69558https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-interaction-between-bia-3-202-and-levodopa-carbidopa-69559https://curecurrent.com/trials/effect-of-melatonin-on-sleep-disturbances-in-patients-with-parkinson-s-disease-69560https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-including-food-interaction-and-pharmacodynamics-of-bia-3-202-69561https://curecurrent.com/trials/absorption-distribution-metabolism-and-excretion-of-14c-labelled-bia-3-202-and-metabolites-69562https://curecurrent.com/trials/study-to-investigate-the-tolerability-steady-state-pharmacokinetics-and-erythrocyte-comt-inhibition-of-bia-3-202-69563https://curecurrent.com/trials/high-intensity-exercise-and-fall-prevention-boot-camp-for-parkinson-s-disease-69564https://curecurrent.com/trials/resistance-versus-balance-training-in-parkinson-s-disease-69565https://curecurrent.com/trials/a-study-in-healthy-male-volunteers-to-investigate-a-new-drug-for-the-treatment-of-parkinson-s-disease-69566https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-interaction-between-four-different-single-doses-of-bia-3-202-and-a-single-dose-of-levodo-69567https://curecurrent.com/trials/study-to-investigate-the-safety-tolerability-steady-state-pharmacokinetic-and-pharmacodynamic-profile-of-bia-3-202-69568https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-interaction-between-four-different-single-doses-of-bia-3-202-and-a-single-dose-of-levodo-69569https://curecurrent.com/trials/deep-brain-stimulation-dbs-of-the-nucleus-basalis-of-meynert-nbm-in-patients-with-parkinson-s-disease-69570https://curecurrent.com/trials/mapping-mood-in-the-subthalamic-nucleus-in-parkinson-s-disease-pd-69571https://curecurrent.com/trials/automated-telehealth-diagnostics-for-remote-parkinson-monitoring-69572https://curecurrent.com/trials/dysarthria-in-parkinson-s-disease-lusophony-vs-francophony-comparison-69573https://curecurrent.com/trials/effect-of-clonazepam-on-rem-sleep-behavior-disorder-in-patients-with-parkinsonism-69574https://curecurrent.com/trials/a-study-of-efficacy-and-safety-of-eltoprazine-hcl-for-treating-levodopa-induced-dyskinesia-in-parkinson-s-disease-patien-69575https://curecurrent.com/trials/study-of-safety-tolerability-pharmacokinetics-and-efficacy-of-abt-slv187-in-subjects-with-advanced-parkinson-s-disease-69576https://curecurrent.com/trials/continuous-behavior-assessment-of-the-effects-of-a-physical-therapy-program-for-patients-with-parkinson-s-disease-69577https://curecurrent.com/trials/efficacy-and-safety-of-afq056-in-reducing-l-dopa-induced-dyskinesias-in-parkinson-s-disease-patients-69578https://curecurrent.com/trials/a-treadmill-training-program-augmented-by-virtual-reality-to-decrease-fall-risk-in-older-adults-69579https://curecurrent.com/trials/mental-practice-in-motor-learning-of-brushing-and-parkinson-disease-69580https://curecurrent.com/trials/a-genetic-and-perfusion-study-of-response-to-cognitive-enhancers-in-lewy-body-disease-69581https://curecurrent.com/trials/adagio-follow-up-study-evaluation-of-the-long-term-effects-of-rasagiline-in-parkinson-s-disease-subjects-69582https://curecurrent.com/trials/acupuncture-as-adjuvant-therapy-for-sleep-disorders-in-parkinson-s-disease-69583https://curecurrent.com/trials/natural-history-of-levodopa-induced-dyskinesia-lid-69584https://curecurrent.com/trials/study-of-the-neuro-protective-effect-of-granulocyte-colony-stimulating-factor-on-early-stage-parkinson-s-disease-69585https://curecurrent.com/trials/parkinson-s-disease-diagnostic-observations-paddo-69586https://curecurrent.com/trials/does-cognitive-impairment-affect-rehabilitation-outcome-in-parkinson-s-disease-69587https://curecurrent.com/trials/sleep-disordered-breathing-and-its-impact-on-neuro-cognitive-performance-and-quality-of-life-in-parkinson-disease-69588https://curecurrent.com/trials/study-to-investigate-the-ability-of-11c-donepezil-pet-to-image-the-parasympathetic-nervous-system-69589https://curecurrent.com/trials/subthalamic-nucleus-connectivity-in-parkinson-s-disease-with-ultra-high-field-magnetic-resonance-imaging-69590https://curecurrent.com/trials/biofeedback-rehabilitation-in-parkinson-s-disease-69591https://curecurrent.com/trials/deep-brain-stimulation-in-patients-with-parkinson-s-disease-69592https://curecurrent.com/trials/gut-derived-neuropeptides-in-cerebrospinal-fluid-of-patients-with-parkinson-s-disease-and-healthy-controls-69593https://curecurrent.com/trials/a-pilot-study-of-oxaloacetate-in-subjects-with-treated-pd-69594https://curecurrent.com/trials/effects-of-physical-activity-on-the-brain-in-parkinson-s-disease-pd-69595https://curecurrent.com/trials/investigation-of-the-efficacy-and-safety-of-incobotulinumtoxina-xeomin-in-parkinson-s-tremor-a-customized-approach-69596https://curecurrent.com/trials/biomarker-discovery-in-parkinson-s-disease-69597https://curecurrent.com/trials/behavior-addictions-improvement-in-parkinson-disease-s-patients-treated-by-subthalamic-stimulation-long-term-follow-up-69598https://curecurrent.com/trials/autologous-peripheral-nerve-grafts-into-the-substantia-nigra-of-subjects-with-pd-undergoing-deep-brain-stimulation-69599https://curecurrent.com/trials/study-to-assess-the-safety-tolerability-and-pharmacokinetic-profile-of-pbf-509-80-mg-160-mg-and-240-mg-after-multiple-or-69600https://curecurrent.com/trials/study-to-assess-the-safety-and-tolerability-of-pbf-509-in-male-healthy-volunteers-69601https://curecurrent.com/trials/aquatic-therapy-versus-land-based-therapy-for-the-treatment-of-balance-dysfunction-in-parkinson-s-disease-69602https://curecurrent.com/trials/effects-of-vitamin-d-in-parkinson-s-disease-pd-69603https://curecurrent.com/trials/striatal-and-extra-striatal-mechanisms-of-falling-in-parkinson-s-disease-69604https://curecurrent.com/trials/characterizing-the-specificity-and-stability-of-local-field-potentials-in-the-globus-pallidus-internus-of-patients-under-69605https://curecurrent.com/trials/mapping-functional-networks-of-brain-activity-using-eeg-in-patients-with-essential-tremor-or-parkinson-disease-before-an-69606https://curecurrent.com/trials/lfp-correlates-of-movement-disorders-69607https://curecurrent.com/trials/duodopa-home-titration-using-telemedicine-evaluation-of-use-of-resources-69608https://curecurrent.com/trials/effect-of-a-lipidic-and-proteic-controlled-diet-on-parkinson-s-disease-69609https://curecurrent.com/trials/phase-1-study-of-npt200-11-in-healthy-subjects-69610https://curecurrent.com/trials/safety-study-to-autonomic-rehabilitation-o-parkinson-s-disease-69611https://curecurrent.com/trials/neurocognitive-effects-of-bilateral-stn-versus-gpi-dbs-in-parkinson-s-disease-patients-with-mci-69612https://curecurrent.com/trials/trodat-1-spect-and-dopamine-polymorphism-69613https://curecurrent.com/trials/parkinson-disease-before-and-after-medication-and-rehabilitation-treatment-69614https://curecurrent.com/trials/effects-of-virtual-reality-based-training-on-posture-stability-in-parkinson-s-disease-69615https://curecurrent.com/trials/imaging-biomarkers-of-progression-of-mobility-impairment-in-parkinson-disease-69616https://curecurrent.com/trials/tango-for-treatment-of-motor-and-non-motor-manifestations-in-parkinson-s-disease-69617https://curecurrent.com/trials/pirlong-pd-safety-and-efficacy-of-piribedil-in-parkinson-s-disease-during-long-term-therapy-69618https://curecurrent.com/trials/consolidation-of-motor-learning-of-writing-skills-and-its-related-brain-activity-changes-in-parkinson-s-disease-69619https://curecurrent.com/trials/effects-of-exercise-on-long-range-autocorrelations-in-parkinson-s-disease-69620https://curecurrent.com/trials/study-on-tolerability-of-repeat-i-c-v-administration-of-snn0031-infusion-solution-in-patients-with-pd-69621https://curecurrent.com/trials/a-study-with-an-increased-dose-step-in-patients-that-have-previously-received-placebo-or-snn0031-69622https://curecurrent.com/trials/possible-use-of-rotigotine-in-subjects-70-years-and-older-with-late-onset-of-disease-69623https://curecurrent.com/trials/evaluation-of-the-long-term-safety-tolerability-and-efficacy-of-perampanel-e2007-as-an-adjunctive-therapy-in-levodopa-tr-69624https://curecurrent.com/trials/effects-of-rasagiline-on-sleep-disturbances-in-parkinson-s-disease-69625https://curecurrent.com/trials/the-long-term-impact-of-initiating-pramipexole-versus-levodopa-in-early-parkinson-s-disease-calm-pd-cohort-study-69626https://curecurrent.com/trials/the-effects-of-l-tyrosine-on-24-hour-blood-pressure-and-heart-rate-in-parkinson-s-disease-69627https://curecurrent.com/trials/effects-of-home-therapeutic-exercises-oriented-for-patients-with-parkinson-s-disease-69628https://curecurrent.com/trials/national-institute-of-neurological-disorders-and-stroke-ninds-parkinson-s-disease-neuroprotection-trial-69629https://curecurrent.com/trials/pharmacokinetic-study-in-healthy-volunteers-69630https://curecurrent.com/trials/efficacy-and-safety-of-f-18-fpcit-pet-in-parkinson-s-disease-and-essential-tremor-patients-69631https://curecurrent.com/trials/imaging-non-motor-symptoms-of-parkinson-s-disease-by-novel-18f-dtbz-and-florbetapir-f-18-pet-69632https://curecurrent.com/trials/efficacy-and-safety-of-jm-010-in-pd-with-levodopa-induced-dyskinesia-69633https://curecurrent.com/trials/ancillary-longitudinal-csf-collection-study-in-the-harvard-biomarker-study-hbs2-69634https://curecurrent.com/trials/ambulatory-parkinson-s-disease-dyskinesia-monitor-for-drug-therapy-titration-69635https://curecurrent.com/trials/kinesia-homeview-home-diary-comparison-69636https://curecurrent.com/trials/deep-brain-stimulation-in-huch-region-between-2006-and-2014-69637https://curecurrent.com/trials/rhythmic-auditory-stimulation-optimalization-for-gait-improvement-in-parkinson-s-disease-beatpark-study-69638https://curecurrent.com/trials/a-clinical-study-of-patients-with-symptomatic-noh-to-assess-sustained-effects-of-droxidopa-therapy-69639https://curecurrent.com/trials/computer-based-cognitive-training-for-individuals-with-parkinson-s-disease-69640https://curecurrent.com/trials/a-trial-of-neurocognitive-and-supportive-therapy-interventions-for-individuals-with-parkinson-s-disease-69641https://curecurrent.com/trials/dbs-under-general-anesthesia-comparison-to-the-standard-technique-69642https://curecurrent.com/trials/mobilaser-study-to-help-with-people-who-are-having-problems-with-their-gait-69643https://curecurrent.com/trials/continuous-delivery-of-levodopa-in-patients-with-advanced-idiopathic-parkinsons-disease-cost-benefit-69644https://curecurrent.com/trials/effect-of-three-multiple-dose-regimens-of-bia-9-1067-at-steady-state-on-the-levodopa-pharmacokinetics-69645https://curecurrent.com/trials/multicentre-study-in-four-parallel-groups-of-parkinson-s-disease-pd-patients-69646https://curecurrent.com/trials/tolerability-pharmacokinetics-and-pharmacodynamics-of-bia-9-1067-69647https://curecurrent.com/trials/pharmacokinetic-interaction-between-bia-9-1067-and-standard-release-levodopa-carbidopa-69648https://curecurrent.com/trials/effect-of-bia-9-1067-on-the-pharmacokinetics-and-pharmacodynamics-of-warfarin-69649https://curecurrent.com/trials/dexmedetomidine-vs-propofol-on-the-recordings-of-deep-brain-activity-measured-through-implanted-stimulators-69650https://curecurrent.com/trials/rotigotine-versus-placebo-to-evaluate-the-efficacy-on-depressive-symptoms-in-idiopathic-parkinson-s-disease-patients-69651https://curecurrent.com/trials/a-double-blind-placebo-controlled-trial-evaluating-rasagiline-effects-on-cognition-in-parkinson-s-disease-patients-with-69652https://curecurrent.com/trials/nilotinib-in-cognitively-impaired-parkinson-disease-patients-001-69653https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-tropicamide-thin-films-to-reduce-hypersalivation-in-parkinson-s-patients-69654https://curecurrent.com/trials/pd4pd-partnered-dance-for-parkinson-disease-69655https://curecurrent.com/trials/translational-research-evaluating-neurocognitive-memory-processes-69656https://curecurrent.com/trials/vascular-abnormalities-in-idiopathic-parkinson-s-disease-69657https://curecurrent.com/trials/web-based-international-multi-center-clinical-study-for-parkinson-s-disease-69658https://curecurrent.com/trials/gastric-retentive-carbidopa-levodopa-in-parkinson-s-patients-a-one-year-open-label-safety-extension-study-69659https://curecurrent.com/trials/treatment-of-depression-in-parkinson-s-disease-trial-69660https://curecurrent.com/trials/effect-of-paracetamol-on-opicapone-pharmacokinetics-in-healthy-volunteers-69661https://curecurrent.com/trials/effect-of-bia-9-1067-at-steady-state-on-the-pharmacokinetics-of-levodopa-carbidopa-and-levodopa-benserazide-69662https://curecurrent.com/trials/acamprosate-for-treatment-of-compulsive-behaviors-and-craving-in-parkinson-s-disease-69663https://curecurrent.com/trials/training-based-on-declarative-memory-cues-improved-gait-in-patients-with-parkinson-s-disease-69664https://curecurrent.com/trials/the-efficacy-safety-and-tolerability-of-e2007-in-levodopa-treated-parkinson-s-disease-patients-with-motor-fluctuations-69665https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-donepezil-aricept-in-parkinson-s-disease-pd-patients-with-dementia-69666https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-interaction-between-three-different-single-doses-of-bia-9-1067-and-a-single-dose-of-cont-69667https://curecurrent.com/trials/a-study-to-compare-the-adhesiveness-of-2-different-rotigotine-patches-used-for-the-treatment-of-parkinson-s-disease-69668https://curecurrent.com/trials/dual-task-practice-in-parkinson-s-disease-69669https://curecurrent.com/trials/study-on-the-relationship-between-environmental-and-occupational-exposure-to-metals-and-parkinson-s-disease-69670https://curecurrent.com/trials/neurogenic-overactive-bladder-treatment-on-parkinson-s-disease-through-back-tibial-nerve-electrostimulation-69671https://curecurrent.com/trials/pharmacokinetics-and-safety-study-of-ly03003-in-patients-with-early-stage-parkinson-s-disease-69672https://curecurrent.com/trials/the-effect-of-pramipexole-on-metabolic-network-activity-compared-with-levodopa-in-early-parkinson-s-disease-69673https://curecurrent.com/trials/clinical-registry-of-patients-under-treatment-with-atypical-antipsychotics-69674https://curecurrent.com/trials/common-noradrenergic-mechanisms-in-parkinson-s-disease-and-l-dopa-induced-dyskinesia-69675https://curecurrent.com/trials/efficacy-and-safety-of-bia-9-1067-in-idiopathic-parkinson-s-disease-patients-69676https://curecurrent.com/trials/study-of-the-effect-of-the-cognitive-orientation-to-daily-occupational-performance-co-op-on-cognitive-impairment-in-park-69677https://curecurrent.com/trials/pioglitazone-in-early-parkinson-s-disease-69678https://curecurrent.com/trials/safety-and-efficacy-study-of-nh004-films-for-relief-of-sialorrhea-symptoms-in-parkinson-s-disease-patients-69679https://curecurrent.com/trials/electromyography-signals-as-biomarkers-for-parkinson-s-disease-69680https://curecurrent.com/trials/a-multiple-ascending-dose-study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ave8112-in-pa-69681https://curecurrent.com/trials/fox-investigation-for-new-discovery-of-biomarkers-69682https://curecurrent.com/trials/efficacy-safety-and-tolerability-study-in-subjects-with-parkinson-s-disease-69683https://curecurrent.com/trials/orthostatic-dysregulation-and-associated-gastrointestinal-dysfunction-in-parkinson-s-disease-evolution-69684https://curecurrent.com/trials/disease-modifying-potential-of-transdermal-nicotine-in-early-parkinson-s-disease-69685https://curecurrent.com/trials/psychoeducational-programme-for-pd-patients-with-stn-dbs-69686https://curecurrent.com/trials/efficacy-and-safety-of-bia-9-1067-in-idiopathic-parkinson-s-disease-patients-with-wearing-off-phenomenon-69687https://curecurrent.com/trials/parkinson-s-disease-genetics-database-69688https://curecurrent.com/trials/effects-of-aerobic-exercise-in-parkinson-s-disease-69689https://curecurrent.com/trials/efficacy-of-acupuncture-and-bee-venom-acupuncture-on-patients-with-idiopathic-parkinson-s-disease-69690https://curecurrent.com/trials/motor-cortex-stimulation-for-parkinson-s-disease-69691https://curecurrent.com/trials/treatment-of-orthostatic-intolerance-in-patients-with-parkinson-s-disease-using-midodrine-69692https://curecurrent.com/trials/computer-based-cognitive-training-for-parkinson-disease-69693https://curecurrent.com/trials/an-open-label-study-in-healthy-male-subjects-to-assess-the-absorption-distribution-metabolism-and-excretion-of-14c-label-69694https://curecurrent.com/trials/single-dose-pharmacokinetics-and-relative-bioavailability-of-two-different-formulations-of-opicapone-69695https://curecurrent.com/trials/effect-of-bia-9-1067-on-the-pharmacokinetics-of-repaglinide-69696https://curecurrent.com/trials/effect-of-rasagiline-on-bia-9-1067-pharmacokinetics-69697https://curecurrent.com/trials/study-of-bia-9-1067-to-investigate-its-effect-on-levodopa-pharmacokinetic-69698https://curecurrent.com/trials/effect-of-bia-9-1067-on-rasagiline-pharmacokinetics-69699https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-interaction-between-each-of-three-diferente-single-doses-of-bia-9-1067-and-a-single-dose-69700https://curecurrent.com/trials/aff008e-observational-phase-1b-follow-up-extension-study-for-patients-with-parkinson-s-disease-after-immunization-with-a-69701https://curecurrent.com/trials/follow-up-study-to-assess-one-boost-immunization-with-affitope-pd01a-with-regard-to-safety-and-clinical-activity-69702https://curecurrent.com/trials/tolerability-and-safety-of-subcutaneous-administration-of-two-doses-of-affitope-pd01a-in-early-parkinson-s-disease-69703https://curecurrent.com/trials/safety-and-efficacy-of-long-term-daily-use-of-mirapex-la-tablets-in-patients-with-parkinson-s-disease-69704https://curecurrent.com/trials/rotigotine-versus-placebo-as-double-blind-study-to-evaluate-the-efficacy-in-early-stage-idiopathic-parkinson-s-disease-p-69705https://curecurrent.com/trials/rasagiline-and-apathy-in-parkinson-s-disease-69706https://curecurrent.com/trials/the-efficacy-and-safety-study-of-high-dose-donepezil-in-parkinson-s-disease-with-dementia-69707https://curecurrent.com/trials/naltrexone-for-impulse-control-disorders-in-parkinson-s-disease-69708https://curecurrent.com/trials/effect-of-lower-extremity-ankle-foot-orthoses-in-parkinson-s-disease-69709https://curecurrent.com/trials/efficacy-and-safety-of-memantine-for-parkinson-s-disease-dementia-pdd-and-dementia-with-lewy-bodies-dlb-69710https://curecurrent.com/trials/the-effect-of-lsvt-loud-for-mandarin-speaking-individuals-with-hypokinetic-dysarthria-due-to-parkinson-s-disease-69711https://curecurrent.com/trials/the-effect-of-tdcs-on-a-motor-cognitive-dual-task-performance-of-parkinson-s-patients-69712https://curecurrent.com/trials/measure-of-microglial-activation-in-the-brain-of-parkinson-disease-patients-with-pet-69713https://curecurrent.com/trials/intravenous-versus-inhalational-anesthesia-in-parkinson-s-disease-69714https://curecurrent.com/trials/evidence-of-neuroplasticity-after-performing-a-cognitive-task-in-idiopathic-parkinson-s-disease-patients-69715https://curecurrent.com/trials/can-tdcs-enhance-efficacy-of-rehabilitative-intervention-for-freezing-of-gait-in-parkinson-s-disease-69716https://curecurrent.com/trials/a-single-period-investigation-to-assess-the-tolerability-of-healthy-subjects-to-oral-sinemet-levodopa-carbidopa-69717https://curecurrent.com/trials/balance-training-in-parkinson-s-disease-using-cues-69718https://curecurrent.com/trials/the-use-of-botox-in-advanced-parkinson-s-patients-experiencing-pain-69719https://curecurrent.com/trials/comparison-of-modafinil-and-methylphenidate-in-treatment-of-excessive-daytime-sleepiness-in-patients-with-parkinson-s-di-69720https://curecurrent.com/trials/randomized-evaluation-of-the-24-hour-coverage-efficacy-of-rotigotine-69721https://curecurrent.com/trials/amplitude-and-rate-of-intrinsic-feedback-during-treadmill-training-for-parkinson-s-disease-69722https://curecurrent.com/trials/mindfulness-based-intervention-mbi-on-the-quality-of-life-and-non-motor-symptoms-nms-of-persons-with-pd-69723https://curecurrent.com/trials/pilot-study-to-assess-effect-of-treatment-and-adherence-in-pd-subjects-69724https://curecurrent.com/trials/words-generation-in-compulsives-gamblers-and-parkinson-s-disease-patients-69725https://curecurrent.com/trials/connecting-the-lab-to-everyday-life-the-relevance-of-executive-dysfunction-to-participation-and-quality-of-life-in-parki-69726https://curecurrent.com/trials/hippotherapy-and-parkinson-s-disease-69727https://curecurrent.com/trials/rehabilitation-of-everyday-memory-impairment-in-parkinson-disease-a-pilot-study-69728https://curecurrent.com/trials/a-study-to-explore-the-safety-and-tolerability-of-doses-of-e2007-up-to-a-maximum-of-8-mg-in-patients-with-parkinson-s-di-69729https://curecurrent.com/trials/11c-donepezil-pet-for-imaging-the-autonomous-nervous-system-in-parkinsons-disease-69730https://curecurrent.com/trials/walking-capacity-in-parkinson-s-disease-pd-walk-69731https://curecurrent.com/trials/resistance-training-in-patients-with-parkinson-s-disease-69732https://curecurrent.com/trials/an-exploratory-randomized-blinded-placebo-controlled-trial-of-folic-acid-and-l-methylfolate-in-parkinson-s-disease-69733https://curecurrent.com/trials/effects-of-tdcs-with-physical-therapy-on-rehabilitation-in-parkinson-s-disease-69734https://curecurrent.com/trials/nurse-management-of-neuromodulation-therapy-69735https://curecurrent.com/trials/study-of-irx4204-for-treatment-of-early-parkinson-s-disease-69736https://curecurrent.com/trials/expectation-and-response-to-levodopa-and-acupuncture-in-parkinson-s-disease-69737https://curecurrent.com/trials/study-to-evaluate-the-efficacy-of-rotigotine-on-parkinson-s-disease-associated-pain-69738https://curecurrent.com/trials/cns-uptake-of-intranasal-glutathione-69739https://curecurrent.com/trials/dbs-frequency-on-swallowing-function-in-parkinson-s-disease-69740https://curecurrent.com/trials/methylphenidate-for-the-treatment-of-gait-impairment-in-parkinson-s-disease-69741https://curecurrent.com/trials/study-to-evaluate-initiation-of-stalevo-in-early-wearing-off-69742https://curecurrent.com/trials/treatments-for-insomnia-in-patients-with-parkinson-s-disease-69743https://curecurrent.com/trials/caffeine-for-motor-manifestations-of-parkinson-s-disease-69744https://curecurrent.com/trials/caffeine-for-excessive-daytime-somnolence-in-parkinson-s-disease-69745https://curecurrent.com/trials/the-cerebellum-as-a-potential-treatment-site-for-pd-motor-symptoms-69746https://curecurrent.com/trials/stress-busting-program-for-caregivers-of-patients-with-neruological-diseases-69747https://curecurrent.com/trials/deep-brain-stimulation-for-parkinson-s-disease-trial-69748https://curecurrent.com/trials/ambulosono-rasagiline-musical-walking-study-69749https://curecurrent.com/trials/net-pd-ls-1-creatine-in-parkinson-s-disease-69750https://curecurrent.com/trials/an-effectiveness-and-toxicity-of-cyberknife-based-radiosurgery-for-parkinson-disease-69751https://curecurrent.com/trials/using-heavy-water-to-study-cell-dynamics-in-parkinson-s-disease-69752https://curecurrent.com/trials/study-of-clozapine-for-the-treatment-of-psychosis-in-patients-with-idiopathic-parkinson-s-disease-69753https://curecurrent.com/trials/the-effects-of-the-hopeful-outdoor-parkinson-exercise-hope-program-on-improving-balance-performance-in-parkinsonian-non-69754https://curecurrent.com/trials/phase-2-double-blind-randomized-controlled-multi-center-clinical-trial-of-the-safety-and-efficacy-of-transplanted-fetal-69755https://curecurrent.com/trials/comparison-of-constant-current-to-constant-voltage-stimulation-in-subthalamic-deep-brain-stimulation-for-parkinson-s-dis-69756https://curecurrent.com/trials/spinal-cord-stimulation-for-the-treatment-of-motor-and-nonmotor-symptoms-of-parkinson-s-disease-69757https://curecurrent.com/trials/parkinstim-transcranial-direct-current-stimulation-for-parkinson-s-disease-69758https://curecurrent.com/trials/fatigue-and-cardiac-sympathetic-denervation-in-parkinson-disease-69759https://curecurrent.com/trials/cellular-proteome-from-leukocytes-of-glaucoma-patients-in-comparison-with-patients-with-parkinson-s-disease-69760https://curecurrent.com/trials/recharge-sub-study-to-the-implantable-systems-performance-registry-ispr-69761https://curecurrent.com/trials/the-effect-of-exercise-on-individuals-with-parkinson-s-disease-69762https://curecurrent.com/trials/impact-of-dance-therapy-on-parkinson-s-disease-69763https://curecurrent.com/trials/slv308-for-treatment-of-patients-with-parkinson-s-disease-experiencing-motor-fluctuations-69764https://curecurrent.com/trials/the-study-of-rest-tremor-suppression-by-using-electrical-muscle-stimulation-69765https://curecurrent.com/trials/development-of-parkinson-s-glove-for-detection-and-suppression-of-hand-tremor-69766https://curecurrent.com/trials/pharmacokinetic-study-in-healthy-males-69767https://curecurrent.com/trials/whole-body-vibration-as-a-treatment-for-parkinson-s-disease-69768https://curecurrent.com/trials/internet-cbt-cognitive-behavioral-therapy-for-depression-and-anxiety-in-parkinsons-disease-69769https://curecurrent.com/trials/single-ascending-dose-study-of-prx002-in-healthy-subjects-69770https://curecurrent.com/trials/melatonin-for-nocturia-in-parkinson-s-disease-69771https://curecurrent.com/trials/the-effect-of-rasagiline-on-cognition-in-parkinson-s-disease-69772https://curecurrent.com/trials/parkinstep-automated-pd-gait-and-balance-assessment-for-optimizing-dbs-69773https://curecurrent.com/trials/an-observational-study-for-the-prevalence-of-neuropsychiatric-symptom-in-parkinson-s-disease-dementia-69774https://curecurrent.com/trials/the-measurement-of-nocturnal-hypokinesia-in-parkinson-s-disease-pd-patient-compared-with-spouse-by-wearable-sensors-69775https://curecurrent.com/trials/a-study-of-mk0657-in-parkinson-s-disease-patients-0657-006-69776https://curecurrent.com/trials/l-dopa-versus-dopamine-agonists-after-subthalamic-nucleus-deep-brain-stimulation-in-parkinson-s-disease-69777https://curecurrent.com/trials/development-of-a-novel-18f-dtbz-pet-imaging-as-a-biomarker-to-monitor-neurodegeneration-of-park6-and-park8-parkinsonism-69778https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-interaction-between-each-of-three-different-single-doses-of-bia-9-1067-and-a-single-dose-69779https://curecurrent.com/trials/study-of-efficacy-safety-and-tolerability-of-levodopa-carbidopa-intestinal-gel-in-levodopa-responsive-parkinson-s-subjec-69780https://curecurrent.com/trials/study-of-efficacy-safety-and-tolerability-of-levodopa-carbidopa-intestinal-gel-in-levodopa-responsive-parkinson-s-subjec-69781https://curecurrent.com/trials/safety-efficacy-study-of-levodopa-carbidopa-intestinal-gel-in-parkinson-s-subjects-69782https://curecurrent.com/trials/levodopa-carbidopa-intestinal-gel-open-label-study-in-advanced-parkinson-s-disease-69783https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-interaction-between-three-different-single-doses-of-bia-9-1067-and-a-single-dose-of-imme-69784https://curecurrent.com/trials/pharmacokinetics-of-bia-9-1067-in-subjects-with-hepatic-impairment-69785https://curecurrent.com/trials/pharmacokinetics-of-bia-9-1067-and-its-metabolites-in-healthy-male-elderly-subjects-and-in-healthy-male-young-subjects-69786https://curecurrent.com/trials/a-study-to-investigate-the-tolerability-and-effect-of-three-single-dose-regimens-of-bia-9-1067-69787https://curecurrent.com/trials/a-safety-and-tolerability-study-of-intracerebroventricular-administration-of-snn0031-to-patients-with-parkinson-s-diseas-69788https://curecurrent.com/trials/absorption-distribution-metabolism-and-excretion-of-14c-labeled-bia-9-1067-and-metabolites-69789https://curecurrent.com/trials/single-dose-study-to-assess-the-pharmacokinetics-of-sch-900800-in-subjects-with-parkinson-s-disease-being-treated-with-l-69790https://curecurrent.com/trials/a-single-oral-ascending-dose-study-of-bia-9-1067-in-healthy-male-subjects-69791https://curecurrent.com/trials/rasagiline-in-early-parkinson-s-disease-patients-not-treated-with-levodopa-in-china-69792https://curecurrent.com/trials/vitamin-b12-status-and-response-to-vitamin-b12-supplementation-in-patients-with-parkinson-s-disease-69793https://curecurrent.com/trials/cognitive-training-in-parkinson-s-disease-69794https://curecurrent.com/trials/pet-study-of-non-motor-symptoms-of-parkinson-disease-69795https://curecurrent.com/trials/effect-of-opicapone-at-steady-state-on-warfarin-pharmacokinetics-69796https://curecurrent.com/trials/developing-objective-measures-of-levodopa-induced-dyskinesia-study-1-69797https://curecurrent.com/trials/the-parkcycle-study-aerobic-exercise-in-pd-69798https://curecurrent.com/trials/evaluation-of-a-biomarker-related-to-the-gi-tract-for-the-diagnosis-of-parkinson-s-disease-69799https://curecurrent.com/trials/relaxation-guided-imagery-for-treatment-of-pain-in-parkinson-s-disease-69800https://curecurrent.com/trials/coping-with-depression-in-parkinson-s-disease-69801https://curecurrent.com/trials/the-effects-of-treadmill-versus-agility-training-in-parkinson-s-disease-69802https://curecurrent.com/trials/development-of-an-instrumented-system-to-measure-mobility-in-parkinson-s-disease-69803https://curecurrent.com/trials/efficacy-of-orally-disintegrating-selegiline-in-parkinson-s-patients-experiencing-adverse-effects-with-dopamine-agonists-69804https://curecurrent.com/trials/pramipexole-extended-release-versus-pramipexole-immediate-release-for-18-weeks-in-chinese-parkinson-s-disease-pd-patient-69805https://curecurrent.com/trials/long-term-extension-of-recover-long-term-effect-of-the-24h-transdermal-delivery-of-rotigotine-in-subjects-with-idiopathi-69806https://curecurrent.com/trials/pharmacologically-active-constituents-of-chocolate-and-their-symptomatic-effects-in-patients-with-idiopathic-parkinson-s-69807https://curecurrent.com/trials/cardiac-effects-of-rotigotine-transdermal-system-in-subjects-with-advanced-stage-idiopathic-parkinson-s-disease-69808https://curecurrent.com/trials/trial-to-assess-parkinson-s-disease-pd-symptom-control-to-four-doses-of-rotigotine-in-a-transdermal-patch-69809https://curecurrent.com/trials/cognitive-behavioral-therapy-for-depression-in-parkinson-s-disease-69810https://curecurrent.com/trials/dietary-modifications-effect-on-continuous-lcig-infusion-outcomes-in-patients-with-advanced-parkinson-apos-s-disease-69811https://curecurrent.com/trials/exercise-interventions-in-parkinson-s-disease-69812https://curecurrent.com/trials/trial-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-rotigotine-in-healthy-korean-subjects-69813https://curecurrent.com/trials/a-multicenter-open-label-trial-to-assess-subject-preference-of-parcopa-carbidopa-levodopa-orally-disintegrating-tablets-69814https://curecurrent.com/trials/strength-and-balance-in-gender-and-age-matched-controls-69815https://curecurrent.com/trials/a-follow-up-study-on-safety-and-tolerability-of-intracerebroventricular-administration-of-snn0031-to-patients-with-parki-69816https://curecurrent.com/trials/magnetic-resonance-mr-guided-functional-ultrasound-neurosurgery-for-movement-disorders-69817https://curecurrent.com/trials/anticholinergic-therapy-for-overactive-bladder-in-parkinson-s-disease-69818https://curecurrent.com/trials/a-trial-of-neupro-rotigotine-transdermal-patch-in-patients-with-parkinson-s-disease-undergoing-surgery-69819https://curecurrent.com/trials/an-open-label-extension-trial-to-assess-the-safety-of-long-term-treatment-of-rotigotine-in-advanced-stage-parkinson-s-di-69820https://curecurrent.com/trials/an-open-label-extension-trial-to-assess-the-safety-of-long-term-treatment-of-rotigotine-in-early-stage-parkinson-s-disea-69821https://curecurrent.com/trials/an-open-label-extension-trial-to-assess-the-safety-and-tolerability-of-long-term-treatment-of-rotigotine-in-subjects-wit-69822https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-rotigotine-nasal-spray-for-the-acute-treatment-of-parkinson-symptoms-69823https://curecurrent.com/trials/an-open-label-extension-trial-to-assess-the-safety-of-long-term-treatment-of-rotigotine-in-advance-stage-parkinson-s-dis-69824https://curecurrent.com/trials/an-open-label-extension-trial-to-assess-the-safety-of-long-term-treatment-of-rotigotine-in-early-stage-parkinson-s-disea-69825https://curecurrent.com/trials/safety-and-tolerability-trial-of-switching-from-ropinirole-to-rotigotine-69826https://curecurrent.com/trials/farming-and-movement-evaluation-study-fame-69827https://curecurrent.com/trials/molecular-epidemiology-of-parkinson-s-disease-69828https://curecurrent.com/trials/neuromodulation-on-motor-function-in-parkinson-s-disease-69829https://curecurrent.com/trials/development-of-a-monitoring-set-up-and-algorithm-using-functional-mri-fmri-and-eeg-for-prediction-of-response-to-repetit-69830https://curecurrent.com/trials/rotigotine-patch-in-subjects-with-advanced-stage-idiopathic-parkinson-s-disease-who-are-not-well-controlled-on-levodopa-69831https://curecurrent.com/trials/tolerability-of-sifrol-in-ambulatory-patients-suffering-from-parkinson-s-disease-69832https://curecurrent.com/trials/a-trial-to-evaluate-the-effects-of-rotigotine-transdermal-patch-on-early-morning-motor-impairment-and-sleep-disorders-id-69833https://curecurrent.com/trials/a-trial-to-compare-the-efficacy-of-rotigotine-transdermal-patch-to-that-of-ropinirole-on-early-morning-motor-impairment-69834https://curecurrent.com/trials/efficacy-and-tolerability-of-sifrol-pramipexole-in-patients-with-advanced-idiopathic-parkinson-s-disease-69835https://curecurrent.com/trials/post-marketing-surveillance-study-of-sifrol-in-patients-with-idiopathic-parkinson-s-disease-69836https://curecurrent.com/trials/post-marketing-surveillance-and-special-surveillance-for-mirapex-tablet-in-patients-with-idiopathic-parkinson-s-disease-69837https://curecurrent.com/trials/a-trial-to-assess-switching-from-ropinirole-pramipexole-or-cabergoline-to-the-rotigotine-transdermal-system-in-idiopathi-69838https://curecurrent.com/trials/accelerated-transcranial-magnetic-stimulation-tms-for-depression-69839https://curecurrent.com/trials/predictive-and-diagnostic-value-of-tau-and-beta-amyloid-markers-in-the-dementia-of-parkinson-s-disease-69840https://curecurrent.com/trials/post-marketing-surveillance-study-in-patients-with-idiopathic-parkinson-s-disease-69841https://curecurrent.com/trials/automated-parkinson-s-disease-pd-motor-symptom-assessment-for-deep-brain-stimulation-dbs-programming-69842https://curecurrent.com/trials/a-double-blind-sham-controled-study-to-evaluate-the-influence-of-low-frequency-repetitive-transcranial-stimulation-r-tms-69843https://curecurrent.com/trials/observational-study-in-parkinson-s-disease-of-the-primary-care-population-of-patients-treated-with-pramipexole-69844https://curecurrent.com/trials/ophthalmologic-safety-of-long-term-treatment-with-pramipexole-compared-to-bromocriptine-or-other-dopamine-agonists-in-pa-69845https://curecurrent.com/trials/the-effect-of-sifrol-on-tremor-and-depression-in-patients-with-idiopathic-parkinson-s-disease-69846https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-switching-from-talipexole-to-pramipexole-in-patients-with-parkinson-s-disease-69847https://curecurrent.com/trials/wiimote-game-controller-as-a-device-to-study-movement-disorders-69848https://curecurrent.com/trials/state-dependent-resonance-in-the-bg-cortical-loops-69849https://curecurrent.com/trials/effectiveness-study-of-occupational-therapy-in-parkinson-s-disease-69850https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-dose-ranging-study-of-the-safety-tolerability-and-efficacy-of-e2007-in-park-69851https://curecurrent.com/trials/open-label-treatment-with-tdcs-for-parkinson-s-and-related-disorders-for-improvement-of-speech-gait-and-mood-69852https://curecurrent.com/trials/the-effect-of-low-frequency-rtms-on-motor-function-in-pd-patients-with-freezing-of-gait-69853https://curecurrent.com/trials/electrophysiological-investigation-and-rtms-intervention-of-ambulatory-central-processing-of-freezing-of-gait-in-parkins-69854https://curecurrent.com/trials/long-term-dopamine-transporter-imaging-and-clinical-assessment-of-parkinson-s-disease-progression-69855https://curecurrent.com/trials/survey-on-pd-patients-with-depressive-symptoms-69856https://curecurrent.com/trials/effect-of-rotigotine-on-motor-symptoms-in-patients-with-advanced-parkinson-s-disease-pd-with-motor-fluctuations-and-symp-69857https://curecurrent.com/trials/a-12-week-study-of-pramipexole-extended-release-er-in-patients-with-parkinson-s-disease-pd-followed-by-a-52-week-long-te-69858https://curecurrent.com/trials/retinal-nerve-fiber-layer-thickness-changes-in-parkinson-disease-a-meta-analysis-69859https://curecurrent.com/trials/efficacy-safety-tolerability-of-pramipexol-er-versus-pramipexol-ir-versus-placebo-in-early-pd-patients-69860https://curecurrent.com/trials/augmenting-effects-of-l-dops-with-carbidopa-and-entacapone-69861https://curecurrent.com/trials/study-of-individuals-with-parkinson-s-symptoms-but-in-whom-there-is-diagnostic-uncertainty-69862https://curecurrent.com/trials/validation-of-datscan-for-detection-of-parkinson-disease-related-disorders-69863https://curecurrent.com/trials/phase-ii-subthalamic-nucleus-stn-vs-globus-pallidus-gpi-trial-69864https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-e2007-in-levodopa-treated-parkinson-s-disease-patients-with-motor-fluctuations-69865https://curecurrent.com/trials/special-survey-on-parkinson-s-disease-patients-treated-long-term-use-of-pramipexole-69866https://curecurrent.com/trials/a-study-of-e2007-as-an-adjunctive-therapy-in-levodopa-treated-parkinson-s-disease-patients-with-motor-fluctuations-69867https://curecurrent.com/trials/long-term-safety-tolerability-and-efficacy-in-perampanel-treated-parkinson-s-disease-patients-with-motor-fluctuations-69868https://curecurrent.com/trials/pivotal-study-in-advanced-parkinsons-disease-patients-69869https://curecurrent.com/trials/assessment-of-the-safety-and-efficacy-of-pramipexole-extended-release-in-patients-with-parkinson-s-disease-in-routine-cl-69870https://curecurrent.com/trials/dexmedetomidine-effects-on-microelectrode-recording-in-deep-brain-stimulation-69871https://curecurrent.com/trials/role-of-mesocorticolimbic-pathway-in-apathy-of-patients-with-parkinson-s-disease-study-using-diffusion-tensor-imaging-an-69872https://curecurrent.com/trials/pramipexole-in-untreated-and-levodopa-treated-parkinson-s-disease-patients-69873https://curecurrent.com/trials/safety-and-efficacy-of-pramipexole-and-bromocriptine-combined-with-l-dopa-in-parkinson-s-disease-69874https://curecurrent.com/trials/efficacy-of-a-robotic-assisted-gait-training-in-addition-to-a-conventional-physical-therapy-in-parkinson-s-disease-69875https://curecurrent.com/trials/bee-venom-for-the-treatment-of-parkinson-disease-69876https://curecurrent.com/trials/long-term-safety-study-of-open-label-pramipexole-extended-release-er-in-patients-with-early-parkinson-s-disease-pd-69877https://curecurrent.com/trials/pramipexole-versus-placebo-in-parkinson-s-disease-pd-patients-with-depressive-symptoms-69878https://curecurrent.com/trials/special-survey-on-parkinson-s-disease-pd-patients-without-concomitant-use-of-l-dopa-69879https://curecurrent.com/trials/safety-of-urate-elevation-in-parkinson-s-disease-69880https://curecurrent.com/trials/evaluation-of-18f-mppf-as-a-brain-tracer-of-serotonin-receptor-5ht1a-69881https://curecurrent.com/trials/a-phase-3b-open-label-safety-and-efficacy-study-of-rotigotine-as-add-on-therapy-with-low-doses-of-pramipexole-or-ropinir-69882https://curecurrent.com/trials/clinical-study-for-adaptive-deep-brain-stimulation-adbs-controlled-by-intracerebral-activity-in-parkinson-s-disease-69883https://curecurrent.com/trials/mapping-functional-networks-of-brain-activity-brain-network-activation-bna-based-on-analysis-of-evoked-response-potentia-69884https://curecurrent.com/trials/an-evaluation-of-the-pharmacokinetics-and-pharmacodynamics-of-ap09004-in-patients-with-parkinson-s-disease-69885https://curecurrent.com/trials/a-placebo-and-ropinirole-controlled-study-for-spm-962-in-advanced-parkinson-s-disease-patients-69886https://curecurrent.com/trials/a-study-of-istradefylline-kw-6002-for-the-treatment-of-parkinson-s-disease-in-patients-taking-levodopa-69887https://curecurrent.com/trials/anesthesia-for-deep-brain-stimulation-69888https://curecurrent.com/trials/clinical-study-of-droxidopa-in-patients-with-neurogenic-orthostatic-hypotension-noh-69889https://curecurrent.com/trials/a-two-part-study-306a-306b-to-assess-droxidopa-in-treatment-of-noh-in-patients-with-parkinson-s-disease-69890https://curecurrent.com/trials/non-motor-symptoms-depressive-symptoms-of-parkinson-s-disease-and-their-course-under-pramipexole-treatment-69891https://curecurrent.com/trials/long-term-safety-study-of-open-label-pramipexole-er-in-patients-with-advanced-pd-69892https://curecurrent.com/trials/a-clinical-study-for-patients-with-neurogenic-orthostatic-hypotension-noh-using-droxidopa-69893https://curecurrent.com/trials/a-randomized-double-blind-active-pramipexole-0-5-mg-tid-and-placebo-controlled-study-of-pramipexole-given-0-5-mg-and-0-7-69894https://curecurrent.com/trials/study-of-mirapex-pramipexole-for-the-early-treatment-of-parkinsons-disease-pd-69895https://curecurrent.com/trials/open-label-clinical-study-of-droxidopa-in-patients-with-neurogenic-orthostatic-hypotension-noh-69896https://curecurrent.com/trials/overnight-switch-trial-from-pramipexole-ir-to-pramipexole-er-in-patients-with-early-parkinson-disease-69897https://curecurrent.com/trials/a-pms-on-safety-profile-of-pramipexole-in-chinese-parkinson-disease-patients-69898https://curecurrent.com/trials/phase-i-deep-brain-stimulation-dbs-vs-best-medical-therapy-bmt-trial-69899https://curecurrent.com/trials/imaging-and-genetic-biomarkers-of-parkinson-disease-pd-onset-and-progression-in-high-risk-families-69900https://curecurrent.com/trials/placebo-controlled-study-in-patients-with-parkinson-s-disease-to-evaluate-the-effect-of-rotigotine-on-non-motor-symptoms-69901https://curecurrent.com/trials/development-of-imaging-clinical-and-biochemical-bio-markers-for-parkinson-s-disease-69902https://curecurrent.com/trials/relaxation-guided-imagery-for-treatment-of-parkinson-s-disease-69903https://curecurrent.com/trials/evaluation-of-5-123i-a-85380-and-spect-imaging-in-individuals-with-parkinsons-disease-69904https://curecurrent.com/trials/famotidine-for-levodopa-induced-dyskinesia-in-pd-69905https://curecurrent.com/trials/a-study-of-brain-imaging-with-nuclear-medicine-technology-in-individuals-with-and-at-risk-for-parkinson-s-disease-69906https://curecurrent.com/trials/study-on-utilization-of-cabergoline-for-compliance-with-risk-minimization-activities-sucre-69907https://curecurrent.com/trials/effects-of-mental-practice-in-gait-of-individuals-with-parkinson-disease-randomized-clinical-trial-69908https://curecurrent.com/trials/the-effects-of-supplementing-tyrosine-on-blood-pressure-in-parkinson-s-disease-69909https://curecurrent.com/trials/effects-of-helicobacter-pylori-infection-eradication-in-patients-with-parkinson-s-disease-69910https://curecurrent.com/trials/influence-of-pramipexole-extended-release-on-medication-adherence-in-parkinson-s-disease-69911https://curecurrent.com/trials/kinetic-tremor-in-parkinsons-disease-its-course-under-pramipexole-mirapexin-treatment-and-impact-on-quality-of-life-69912https://curecurrent.com/trials/first-presentation-of-parkinson-disease-patients-to-neurologist-69913https://curecurrent.com/trials/a-phase-4-open-label-study-to-assess-the-feasibility-and-efficacy-on-motor-and-non-motor-symptoms-of-switching-from-pram-69914https://curecurrent.com/trials/determination-of-muscle-strength-in-parkinsonian-patients-through-the-use-of-an-isokinetic-dynamometer-69915https://curecurrent.com/trials/a-retrospective-study-of-the-relationship-between-white-matter-hyperintensities-wmhs-within-the-cholinergic-pathways-and-69916https://curecurrent.com/trials/mirt-and-rotigotine-in-the-early-stage-of-pd-69917https://curecurrent.com/trials/hallux-mobilization-in-patients-with-parkinson-s-disease-69918https://curecurrent.com/trials/crossover-versus-stabilometric-platform-in-parkinson-s-disease-69919https://curecurrent.com/trials/effects-of-a-rehabilitation-treatment-on-balance-in-pd-evaluated-with-a-stabilometric-platform-69920https://curecurrent.com/trials/analysis-of-the-parameters-obtained-on-stabilometric-platform-in-patients-with-pd-69921https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-pimavanserin-in-patients-with-parkinson-s-disease-psychosis-69922https://curecurrent.com/trials/structured-physical-activity-for-sleep-quality-and-daytime-sleepiness-in-patients-with-parkinson-s-disease-69923https://curecurrent.com/trials/a-long-term-extension-trial-from-of-spm-962-in-advanced-parkinson-s-disease-patients-69924https://curecurrent.com/trials/a-placebo-controlled-study-for-spm-962-in-early-parkinson-s-disease-patients-69925https://curecurrent.com/trials/a-long-term-extension-trial-from-phase-ii-iii-of-spm-962-in-early-parkinson-s-disease-patients-69926https://curecurrent.com/trials/a-dose-ranging-study-for-spm-962-in-parkinson-s-disease-patients-69927https://curecurrent.com/trials/a-dose-finding-study-for-spm-962-in-advanced-parkinson-s-disease-patients-69928https://curecurrent.com/trials/a-long-term-extension-trial-from-late-phase-ii-of-spm-962-in-advanced-parkinson-s-disease-patients-69929https://curecurrent.com/trials/ophthalmologic-safety-study-of-pramipexole-immediate-release-ir-versus-ropinirole-in-early-parkinson-s-disease-pd-patien-69930https://curecurrent.com/trials/study-in-advanced-parkinson-s-disease-patients-with-predictable-motor-fluctuations-69931https://curecurrent.com/trials/the-effects-of-the-rivastigmine-patch-on-parkinson-s-disease-with-memory-and-or-thinking-problems-69932https://curecurrent.com/trials/executive-control-analysis-in-patients-suffering-from-parkinson-disease-and-treated-by-deep-brain-stimulation-69933https://curecurrent.com/trials/optimizing-dbs-electrode-placement-and-programming-69934https://curecurrent.com/trials/working-on-asymmetry-in-parkinson-s-disease-69935https://curecurrent.com/trials/a-randomised-placebo-controlled-study-of-oxn-pr-for-severe-parkinson-s-disease-associated-pain-69936https://curecurrent.com/trials/pedunculopontine-nucleus-stimulation-for-gait-disorders-in-parkinson-s-disease-69937https://curecurrent.com/trials/beware-body-awareness-training-in-the-treatment-of-wearing-off-related-anxiety-in-patients-with-parkinson-s-disease-69938https://curecurrent.com/trials/parkinson-s-disease-registry-69939https://curecurrent.com/trials/investigating-the-pathophysiological-roles-of-cortical-sub-thalamic-nuclear-and-pedunculo-pontine-nuclear-oscillation-in-69940https://curecurrent.com/trials/the-effects-of-auditory-cueing-on-rhythmic-movement-and-cortical-excitability-in-patients-with-parkinson-s-disease-69941https://curecurrent.com/trials/rasagiline-for-the-symptomatic-treatment-of-fatigue-in-parkinson-s-disease-69942https://curecurrent.com/trials/gait-training-with-cognitive-tasks-in-parkinson-s-disease-69943https://curecurrent.com/trials/efficacy-of-transdermal-nicotine-on-motor-symptoms-in-advanced-parkinson-s-disease-69944https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-safety-and-tolerability-of-single-and-multiple-doses-of-rasagiline-69945https://curecurrent.com/trials/progeni-parkinson-s-research-the-organized-genetics-initiative-family-study-of-lrrk2-leucine-rich-repeat-kinase-2-69946https://curecurrent.com/trials/deep-brain-stimulation-follow-up-after-10-years-69947https://curecurrent.com/trials/caregivers-and-physicians-treatment-preference-in-parkinson-patients-treated-with-neupro-requiring-caregiver-support-69948https://curecurrent.com/trials/levetiracetam-treatment-in-adult-subjects-with-parkinson-s-disease-experiencing-troublesome-dyskinesias-69949https://curecurrent.com/trials/a-study-of-aav-haadc-2-in-subjects-with-parkinson-s-disease-69950https://curecurrent.com/trials/study-of-azilect-rasagiline-in-levodopa-treated-parkinson-s-disease-patients-with-motor-fluctuations-in-korea-69951https://curecurrent.com/trials/a-study-assessing-change-in-sense-of-smell-after-rasagiline-use-in-parkinson-s-patients-69952https://curecurrent.com/trials/requirement-of-propofol-for-induction-of-unconsciousness-in-patients-with-parkinson-s-disease-69953https://curecurrent.com/trials/genetic-polymorphism-and-parkinson-s-disease-in-taiwanese-69954https://curecurrent.com/trials/remifentanil-requirement-in-patients-receiving-surgical-treatment-of-parkinson-s-disease-69955https://curecurrent.com/trials/efficacy-and-safety-proof-of-concept-study-in-patients-with-parkinson-s-disease-and-end-of-dose-motor-fluctuations-69956https://curecurrent.com/trials/non-interventional-observational-study-on-who-5-questionnaire-application-in-parkinson-s-disease-69957https://curecurrent.com/trials/impulse-control-disorders-in-parkinson-s-patients-treated-with-pramipexole-and-other-agents-dominion-study-69958https://curecurrent.com/trials/the-differential-diagnosis-of-parkinson-s-disease-and-parkinsonism-by-positron-emission-tomography-69959https://curecurrent.com/trials/special-survey-on-pd-patients-with-renal-dysfunction-69960https://curecurrent.com/trials/evaluation-of-18f-mk-9470-as-a-brain-tracer-of-cannabinoid-1-receptor-in-parkinson-s-disease-and-healthy-subjects-69961https://curecurrent.com/trials/aripiprazole-in-patients-with-psychosis-associated-with-parkinson-s-disease-69962https://curecurrent.com/trials/randomized-single-blind-placebo-controlled-comparative-trial-of-pramipexole-and-bromocriptine-in-parkinson-s-disease-69963https://curecurrent.com/trials/non-interventional-observational-study-with-pramipexole-impact-on-non-motor-symptoms-in-parkinson-s-disease-69964https://curecurrent.com/trials/the-effect-of-e2007-on-pharmacodynamic-responses-to-levodopa-among-patients-with-parkinson-s-disease-who-experience-dysk-69965https://curecurrent.com/trials/apolipoprotein-d-apod-in-human-serum-as-marker-of-parkinson-s-disease-69966https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-five-parallel-groups-efficacy-and-safety-study-of-ns-2330-tesofensine-0-125-69967https://curecurrent.com/trials/motion-safinamide-in-early-ipd-as-add-on-to-dopamine-agonist-69968https://curecurrent.com/trials/a-fourteen-week-placebo-controlled-dose-response-efficacy-and-safety-study-of-ns-2330-in-early-parkinson-s-disease-patie-69969https://curecurrent.com/trials/comfort-and-tolerance-of-surface-neuro-muscular-electrical-stimulation-in-parkinson-s-disease-69970https://curecurrent.com/trials/freezing-of-gait-correction-and-fall-prevention-developing-a-real-time-somatosensory-stimulation-system-69971https://curecurrent.com/trials/a-retrospective-study-of-the-effects-of-different-parameters-on-motor-symptoms-of-pd-in-bilateral-stn-stimulation-69972https://curecurrent.com/trials/effect-of-undenatured-cysteine-rich-whey-protein-isolate-hms-90-in-patients-with-parkinson-s-disease-69973https://curecurrent.com/trials/motor-performance-in-parkinson-s-disease-after-high-intensive-exercise-or-deep-brain-stimulation-69974https://curecurrent.com/trials/effect-of-robot-assisted-gait-training-on-freezing-of-gait-in-parkinson-s-disease-69975https://curecurrent.com/trials/memantine-versus-placebo-in-parkinson-s-disease-dementia-or-dementia-with-lewy-bodies-69976https://curecurrent.com/trials/clinical-trial-of-rasagiline-in-levodopa-treated-parkinson-s-disease-patients-with-motor-fluctuations-69977https://curecurrent.com/trials/motor-response-to-sildenafil-in-pd-69978https://curecurrent.com/trials/study-to-compare-the-effect-of-ropinirole-prolonged-release-once-daily-versus-twice-daily-69979https://curecurrent.com/trials/a-triple-blinded-randomised-placebo-controlled-trial-to-examine-the-efficacy-and-safety-of-vineuro-in-patients-with-park-69980https://curecurrent.com/trials/a-single-center-randomized-double-blind-crossover-pilot-trial-comparing-the-onset-of-action-of-parcopa-with-sinemet-in-s-69981https://curecurrent.com/trials/effects-of-breath-and-stacking-spirometry-incentive-in-patients-with-parkinson-s-disease-69982https://curecurrent.com/trials/124i-mibg-tracer-evaluation-of-myocardial-sympathetic-denervation-and-assessment-of-neuroendocrine-tumors-69983https://curecurrent.com/trials/study-for-rasagiline-effect-on-sleep-trial-rest-in-parkinson-s-disease-69984https://curecurrent.com/trials/a-randomized-controlled-feasibility-trial-to-determine-the-effectiveness-of-set-dancing-for-people-with-parkinson-s-dise-69985https://curecurrent.com/trials/the-impact-of-pharmacological-and-electric-modulation-of-nmda-pathway-on-the-cognitive-flexibility-and-volitional-moveme-69986https://curecurrent.com/trials/nocturnal-parkinson-s-disease-symptoms-study-group-69987https://curecurrent.com/trials/deep-brain-stimulation-effects-study-69988https://curecurrent.com/trials/basal-ganglia-local-field-potentials-in-gait-and-speech-69989https://curecurrent.com/trials/a-study-to-assess-safety-and-tolerability-of-oral-azd3241-in-patients-with-parkinson-s-disease-69990https://curecurrent.com/trials/the-effects-of-vitamin-d-and-bone-loss-in-parkinson-s-disease-69991https://curecurrent.com/trials/effects-of-high-dose-coenzyme-q10-on-biomarkers-of-oxidative-damage-and-clinical-outcome-in-parkinson-disease-69992https://curecurrent.com/trials/executive-activities-of-daily-living-and-cholinergic-functions-in-parkinson-s-disease-69993https://curecurrent.com/trials/evaluation-of-the-effect-of-repetitive-transcranial-magnetic-stimulation-in-pain-perception-in-parkinson-s-disease-69994https://curecurrent.com/trials/study-of-sexuality-in-parkinson-disease-69995https://curecurrent.com/trials/study-of-kw-6002-istradefylline-in-parkinson-s-disease-in-patients-with-motor-response-complications-on-levodopa-69996https://curecurrent.com/trials/treatment-of-insomnia-in-patients-with-parkinson-s-disease-a-multi-site-placebo-controlled-study-of-eszopiclone-69997https://curecurrent.com/trials/increased-gut-permeability-to-lipopolysaccharides-lps-in-parkinson-s-disease-69998https://curecurrent.com/trials/change-in-gastrointestinal-complaints-after-switch-from-oral-parkinson-s-disease-treatment-to-neupro-transdermal-patch-69999https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-e2007-in-levodopa-treated-parkinson-s-disease-patients-with-motor-fluctuations-70000https://curecurrent.com/trials/neuroimaging-studies-of-depression-in-parkinson-s-disease-70001